TWI892269B - Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element - Google Patents
Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display elementInfo
- Publication number
- TWI892269B TWI892269B TW112140282A TW112140282A TWI892269B TW I892269 B TWI892269 B TW I892269B TW 112140282 A TW112140282 A TW 112140282A TW 112140282 A TW112140282 A TW 112140282A TW I892269 B TWI892269 B TW I892269B
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- group
- formula
- crystal alignment
- polymer
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1003—Preparatory processes
- C08G73/1007—Preparatory processes from tetracarboxylic acids or derivatives and diamines
- C08G73/1028—Preparatory processes from tetracarboxylic acids or derivatives and diamines characterised by the process itself, e.g. steps, continuous
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1042—Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1067—Wholly aromatic polyimides, i.e. having both tetracarboxylic and diamino moieties aromatically bound
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1067—Wholly aromatic polyimides, i.e. having both tetracarboxylic and diamino moieties aromatically bound
- C08G73/1071—Wholly aromatic polyimides containing oxygen in the form of ether bonds in the main chain
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1085—Polyimides with diamino moieties or tetracarboxylic segments containing heterocyclic moieties
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/13378—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation
- G02F1/133788—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation by light irradiation, e.g. linearly polarised light photo-polymerisation
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nonlinear Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mathematical Physics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
Description
本發明係有關一種光配向法用的液晶配向劑,特別是提供一種可降低驅動後亮度變化率之光配向法用的液晶配向劑、使用此液晶配向劑所形成的液晶配向膜,以及包含此液晶配向膜的液晶顯示元件。The present invention relates to a liquid crystal alignment agent for photo-alignment method, and in particular to a liquid crystal alignment agent for photo-alignment method capable of reducing the brightness variation rate after driving, a liquid crystal alignment film formed using the liquid crystal alignment agent, and a liquid crystal display device including the liquid crystal alignment film.
習知之液晶顯示單元係廣泛地作為個人電腦、智慧手機、可攜式電話或電視收視機等的顯示部件。液晶顯示單元可包含如夾持於元件基板與彩色濾光片基板間之液晶層、對於液晶層施加電場之畫素電極及共通電極、控制液晶層之液晶分子的配向性之配向膜,以及切換供給至畫素電極之電子訊號的薄膜電晶體(TFT)等。就液晶分子之驅動方式而言,已知有TN(扭曲向列型;Twisted Nematic)方式與VA(垂直對齊;Vertical Alignment)方式等縱電場方式,以及IPS(平面切換;In-Plane Switching)方式與FFS(邊緣場切換;Fringe Field Switching)方式等橫電場方式。Liquid crystal display units are widely used as display components for personal computers, smart phones, portable phones, and television sets. Liquid crystal display units may include, for example, a liquid crystal layer sandwiched between a device substrate and a color filter substrate, pixel electrodes and a common electrode for applying an electric field to the liquid crystal layer, an alignment film for controlling the alignment of the liquid crystal molecules in the liquid crystal layer, and thin-film transistors (TFTs) for switching the electronic signals supplied to the pixel electrodes. As for the driving methods of liquid crystal molecules, there are known longitudinal electric field methods such as the TN (Twisted Nematic) method and the VA (Vertical Alignment) method, and transverse electric field methods such as the IPS (In-Plane Switching) method and the FFS (Fringe Field Switching) method.
目前,工業上最普及的液晶配向膜係對已形成在電極基板上由聚醯胺酸及/或其經醯亞胺化獲得之聚醯亞胺所構成之膜表面,以綿、尼龍或聚酯等布沿一方向進行摩擦處理所製得。摩擦處理係簡便且生產率高之工業常用方法。但是,伴隨液晶顯示元件之高性能化、高精細化與大型化,配向膜表面因摩擦處理所產生之灰塵、機械力與靜電而形成傷痕,進而導致配向處理面內之不均勻性等各種問題產生。作為替代摩擦處理之配向處理方法,已知有藉由照射經偏光之放射線來賦予液晶配向能力之光配向法。針對光配向法,日本特開專利平9-297313號公報已揭露利用光異構化反應者、利用光交聯反應者或利用光分解反應者等。Currently, the most popular liquid crystal alignment film in the industry is made by rubbing the surface of a film composed of polyamide and/or polyimide obtained by imidization, which has been formed on an electrode substrate, in one direction using a cloth such as cotton, nylon or polyester. Rubbing treatment is a simple and highly productive industrial method. However, with the increasing performance, precision and size of liquid crystal display devices, the surface of the alignment film is scratched by dust, mechanical force and static electricity generated by the friction treatment, which in turn leads to various problems such as unevenness within the alignment treatment surface. As an alignment treatment method that replaces friction treatment, a photoalignment method is known that imparts alignment ability to liquid crystals by irradiating them with polarized radiation. Regarding the photoalignment method, Japanese Patent Laid-Open No. 9-297313 discloses the use of a photoisomerization reaction, a photocrosslinking reaction, or a photodecomposition reaction.
然而,含有利用光配向法所製得之習知液晶配向膜的液晶顯示單元仍具有較差之驅動後亮度變化率,而無法滿足應用需求。However, liquid crystal display cells containing conventional liquid crystal alignment films produced using the photo-alignment method still have poor brightness change rates after driving and cannot meet application requirements.
有鑑於此,本發明之一態樣是在提供一種光配向法用的液晶配向劑,其包含聚合物(A)與溶劑(C)。利用此液晶配向劑所形成之液晶配向膜可降低液晶顯示單元之驅動後亮度變化率。In view of this, one aspect of the present invention is to provide a liquid crystal alignment agent for photo-alignment method, which comprises a polymer (A) and a solvent (C). The liquid crystal alignment film formed by using this liquid crystal alignment agent can reduce the brightness change rate of the liquid crystal display unit after driving.
本發明之另一態樣是在提供一種液晶配向膜,其係利用上述光配向法用的液晶配向劑所形成。Another aspect of the present invention is to provide a liquid crystal alignment film formed using the liquid crystal alignment agent used in the above-mentioned photo-alignment method.
本發明之又一態樣是在提供一種液晶顯示元件,其包含前述之液晶配向膜,而具有低驅動後亮度變化率。Another aspect of the present invention is to provide a liquid crystal display element comprising the aforementioned liquid crystal alignment film and having a low brightness change rate after driving.
根據本發明之上述態樣,提出一種光配向法用的液晶配向劑,且此液晶配向劑包含聚合物(A)與溶劑(C)。除聚合物(A)外,本發明光配向法用的液晶配向劑亦可選擇性地包含聚合物(B)。以下析述之。According to the aforementioned aspects of the present invention, a liquid crystal alignment agent for photo-alignment methods is provided, comprising a polymer (A) and a solvent (C). In addition to polymer (A), the liquid crystal alignment agent for photo-alignment methods of the present invention may also optionally comprise a polymer (B). This is described below.
聚合物(A)Polymer (A)
本發明之聚合物(A)可選自於由四羧酸二酐組份(a1)及二胺組份(a2)所反應獲得之聚醯亞胺前驅物,以及聚醯亞胺前驅物之醯亞胺化聚合物所組成之群組中的至少一種聚合物。舉例而言,聚合物(A)可例如包含具聚醯胺酸及聚醯胺酸酯等醯亞胺前驅物結構之聚醯亞胺前驅物,以及/或者該聚醯亞胺前驅物之醯亞胺化物(即聚醯亞胺)。The polymer (A) of the present invention can be at least one polymer selected from the group consisting of polyimide precursors obtained by reacting a tetracarboxylic dianhydride component (a1) with a diamine component (a2), and imidized polymers of polyimide precursors. For example, polymer (A) can include a polyimide precursor having an imide precursor structure such as polyamic acid and polyamic acid ester, and/or an imidized product of such a polyimide precursor (i.e., a polyimide).
聚合物(A)之聚醯亞胺前驅物可包含如下式(I)與式(II)所示之結構。 (I) (II) The polyimide precursor of polymer (A) may include structures represented by the following formulas (I) and (II). (I) (II)
於式(I)中,X 1代表如下式(I-1)所示之結構;X 2代表氫原子或碳數為1至4之烷基;A 1和A 2代表二價之芳香環基團,且環部分可以具有取代基,其中A 1和A 2是相同的;Y 11代表 ,且R 1代表受熱而脫離的基團;Y 12代表單鍵、氧原子或硫原子;Z 1代表具有鏈狀烴結構和脂環烴結構的至少一者且碳數為1至15之二價有機基團,其中當Y 12代表硫原子時,Z 1所代表之二價有機基團之碳數不小於2。 (I-1) In formula (I), X1 represents a structure shown in formula (I-1) below; X2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; A1 and A2 represent divalent aromatic ring groups, and the ring moieties may have substituents, wherein A1 and A2 are the same; Y11 represents , and R 1 represents a group that is thermally dissociated; Y 12 represents a single bond, an oxygen atom, or a sulfur atom; Z 1 represents a divalent organic group having at least one of a chain hydrocarbon structure and an alicyclic hydrocarbon structure and having a carbon number of 1 to 15, wherein when Y 12 represents a sulfur atom, the carbon number of the divalent organic group represented by Z 1 is not less than 2. (I-1)
於式(I-1)中,X 11、X 12、X 13與X 14分別獨立地代表氫原子、鹵素原子、碳數1至6之烷基、碳數為2至6的烯基、碳數為2至6的炔基、含有氟原子且碳數為1至6的一價有機基團或苯基,X 11至X 14為相同或不相同,且X 11、X 12、X 13與X 14之至少一者不為氫原子。 在一些實施例中,X 1代表如式(I-1-1)所示之結構。 (I-1-1) In Formula (I-1), X 11 , X 12 , X 13 , and X 14 each independently represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group having 1 to 6 carbon atoms and containing a fluorine atom, or a phenyl group. X 11 to X 14 may be the same or different, and at least one of X 11 , X 12 , X 13 , and X 14 is not a hydrogen atom. In some embodiments, X 1 represents the structure shown in Formula (I-1-1). (I-1-1)
在一些實施例中,式(I)中之A 1與A 2可代表自苯環、吡啶環或嘧啶環的環部分去除二個氫原子而成的二價基團,其中環部分可以具有取代基,且A 1和A 2是相同的;而Z 1代表 ,且n代表1至5之整數。 In some embodiments, A1 and A2 in formula (I) may represent a divalent group formed by removing two hydrogen atoms from a ring portion of a benzene ring, a pyridine ring, or a pyrimidine ring, wherein the ring portion may have a substituent, and A1 and A2 are the same; and Z1 represents , and n represents an integer from 1 to 5.
於式(II)中,X 1與X 2之定義如前所述;Y 21代表單鍵、-O-、-S-、-S-S-、-SO 2-、-CO-、 、 、-C(CH 3) 2-、-C(CF 3) 2-、-(CH 2) m-、-O-(CH 2) m-O-或-S-(CH 2) m-S-,其中m代表1至12之整數;Y 22代表單鍵、-O-、-S-、-CO-、-C(CH 3) 2-、-C(CF 3) 2-或碳數為1至10之伸烷基。 In formula (II), X1 and X2 are as defined above; Y21 represents a single bond, -O-, -S-, -SS-, -SO2- , -CO-, 、 , -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -(CH 2 ) m -, -O-(CH 2 ) m -O-, or -S-(CH 2 ) m -S-, wherein m represents an integer from 1 to 12; Y 22 represents a single bond, -O-, -S-, -CO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, or an alkylene group having 1 to 10 carbon atoms.
在一些實施例中,式(II)中之Y 21與Y 22可分別獨立地代表-O-或-S-。 In some embodiments, Y 21 and Y 22 in formula (II) can each independently represent —O— or —S—.
若聚合物(A)不包含如式(I)與式(II)所示之結構時,含有此液晶配向劑所形成之液晶配向膜的液晶顯示單元之驅動後亮度變化率不佳。If the polymer (A) does not contain the structures shown in formula (I) and formula (II), the liquid crystal alignment film formed by the liquid crystal alignment agent has a poor brightness change rate after driving.
四羧酸二酐組份(a1)Tetracarboxylic dianhydride component (a1)
本發明前述與二胺組份(a2)反應之四羧酸二酐組份(a1)除可使用四羧酸二酐化合物外,亦可使用四羧酸二鹵化物、四羧酸二烷基酯,或四羧酸二烷基酯二鹵化物等之四羧酸二酐衍生物。四羧酸二酐組份(a1)可單獨使用一種四羧酸二酐化合物或其衍生物,也可混合複數種組合使用。In the present invention, the tetracarboxylic dianhydride component (a1) that reacts with the diamine component (a2) may be a tetracarboxylic dianhydride compound, or a tetracarboxylic dianhydride derivative such as a tetracarboxylic acid dihalide, a tetracarboxylic acid dialkyl ester, or a tetracarboxylic acid dialkyl ester dihalide. The tetracarboxylic dianhydride component (a1) may be a single tetracarboxylic dianhydride compound or its derivative, or a combination of multiple tetracarboxylic dianhydride compounds may be used.
四羧酸二酐組份(a1)可包含式(A11)所示之脂環族四羧酸二酐(a1-1)與其他四羧酸二酐(a1-2)。The tetracarboxylic dianhydride component (a1) may include an alicyclic tetracarboxylic dianhydride (a1-1) represented by formula (A11) and other tetracarboxylic dianhydrides (a1-2).
式(A11)所示之脂環族四羧酸二酐(a1-1)Alicyclic tetracarboxylic dianhydride (a1-1) represented by formula (A11)
用以反應獲得聚合物(A)之四羧酸二酐組份(a1)可包含如下式(A11)所示之脂環族四羧酸二酐(a1-1)或其衍生物。式(A11)所示之脂環族四羧酸二酐(a1-1)或其衍生物可由單獨一種四羧酸二酐或其衍生物所構成,也可由複數種四羧酸二酐或其衍生物所構成。 (A11) The tetracarboxylic dianhydride component (a1) used in the reaction to obtain the polymer (A) may comprise an alicyclic tetracarboxylic dianhydride (a1-1) or a derivative thereof represented by the following formula (A11). The alicyclic tetracarboxylic dianhydride (a1-1) or a derivative thereof represented by formula (A11) may be composed of a single tetracarboxylic dianhydride or a derivative thereof, or may be composed of a plurality of tetracarboxylic dianhydrides or derivatives thereof. (A11)
於式(A11)中,X 11、X 12、X 13與X 14之定義分別如前所述。 In formula (A11), X 11 , X 12 , X 13 and X 14 are as defined above.
當式(A11)中之X 11、X 12、X 13與X 14具有立體障礙結構的情況時,其會導致液晶配向劑的液晶配向性不佳。因此,X 11、X 12、X 13與X 14較佳可為氫原子、甲基或乙基,且更佳為甲基。 When X 11 , X 12 , X 13 , and X 14 in formula (A11) have a sterically hindered structure, this can result in poor liquid crystal alignment properties of the liquid crystal aligner. Therefore, X 11 , X 12 , X 13 , and X 14 are preferably hydrogen atoms, methyl groups, or ethyl groups, and more preferably methyl groups.
在一些具體例中,式(A11)所示之脂環族四羧酸二酐(a1-1)可包含但不限於如下式(A11-1)至(A11-8)所示之化合物。基於含有此液晶配向劑所形成之液晶配向膜的液晶顯示單元之驅動後亮度變化率,式(A11)所示之脂環族四羧酸二酐(a1-1)較佳可為如式(A11-1)所示之化合物。 式(A11-1) 式(A11-2) 式(A11-3) 式(A11-4) 式(A11-5) 式(A11-6) 式(A11-7) 式(A11-8) In some specific embodiments, the alicyclic tetracarboxylic dianhydride (a1-1) represented by formula (A11) may include, but is not limited to, compounds represented by the following formulas (A11-1) to (A11-8). Based on the post-drive brightness change rate of a liquid crystal display unit formed with a liquid crystal alignment film containing this liquid crystal alignment agent, the alicyclic tetracarboxylic dianhydride (a1-1) represented by formula (A11) is preferably a compound represented by formula (A11-1). Formula (A11-1) Formula (A11-2) Formula (A11-3) Formula (A11-4) Formula (A11-5) Formula (A11-6) Formula (A11-7) Formula (A11-8)
基於四羧酸二酐組份(a1)的總使用量為100莫耳,式(A11)所示之脂環族四羧酸二酐(a1-1)的使用量可為30莫耳至100莫耳,較佳為40莫耳至100莫耳,且更佳為50莫耳至100莫耳。Based on the total usage amount of the tetracarboxylic dianhydride component (a1) being 100 mol, the usage amount of the alicyclic tetracarboxylic dianhydride (a1-1) represented by formula (A11) can be 30 mol to 100 mol, preferably 40 mol to 100 mol, and more preferably 50 mol to 100 mol.
若四羧酸二酐組份(a1)不包含如式(A11)所示之脂環族四羧酸二酐(a1-1)時,含有此液晶配向劑所形成之液晶配向膜的液晶顯示單元之驅動後亮度變化率不佳。If the tetracarboxylic dianhydride component (a1) does not contain the alicyclic tetracarboxylic dianhydride (a1-1) represented by formula (A11), the liquid crystal alignment film formed with the liquid crystal alignment agent has a poor brightness change rate after driving.
其他四羧酸二酐(a1-2)Other tetracarboxylic dianhydrides (a1-2)
其他四羧酸二酐(a1-2)可包含如下式(A12)所示之四羧酸二酐化合物及其衍生物。 (A12) Other tetracarboxylic dianhydrides (a1-2) may include tetracarboxylic dianhydride compounds represented by the following formula (A12) and derivatives thereof. (A12)
於式(A12)中,X 1'可代表如下式(A12-1)至式(A12-32)所示之結構,其中「*」代表鍵結位置。 (A12-1) (A12-2) (A12-3) (A12-4) (A12-5) (A12-6) (A12-7) (A12-8) (A12-9) (A12-10) (A12-11) (A12-12) (A12-13) (A12-14) (A12-15) (A12-16) (A12-17) (A12-18) (A12-19) (A12-20) (A12-21) (A12-22) (A12-23) (A12-24) (A12-25) (A12-26) (A12-27) (A12-28) (A12-29) (A12-30) (A12-31) (A12-32) In formula (A12), X 1 ′ can represent the structures shown in the following formulas (A12-1) to (A12-32), wherein “*” represents a bonding position. (A12-1) (A12-2) (A12-3) (A12-4) (A12-5) (A12-6) (A12-7) (A12-8) (A12-9) (A12-10) (A12-11) (A12-12) (A12-13) (A12-14) (A12-15) (A12-16) (A12-17) (A12-18) (A12-19) (A12-20) (A12-21) (A12-22) (A12-23) (A12-24) (A12-25) (A12-26) (A12-27) (A12-28) (A12-29) (A12-30) (A12-31) (A12-32)
於式(A12-5)和式(A12-6)中,X 11'及X 12'分別獨立地代表單鍵、-O-、-CO-、-COO-、伸苯基、磺醯基或醯胺基,且複數個X 12'可彼此相同或不同。式(A12-5)之a1代表0或1之整數;式(A12-6)之a1代表0或1之整數。於式(A12-14)中,X 13'分別獨立地代表氫原子、鹵素原子、碳數為1至6之烷基、碳數為2至6之烯基、碳數為2至6之炔基、含有氟原子且碳數為1至6之一價有機基,或苯基,且複數個X 13'可彼此相同或不同。基於液晶配向性之觀點,X 13'較佳代表氫原子、鹵素原子、甲基或乙基,且更佳代表氫原子或甲基。 In Formula (A12-5) and Formula (A12-6), X 11 ' and X 12 ' each independently represent a single bond, -O-, -CO-, -COO-, a phenylene group, a sulfonyl group, or an amide group, and multiple X 12 ' groups may be the same or different. a1 in Formula (A12-5) represents an integer of 0 or 1; a1 in Formula (A12-6) represents an integer of 0 or 1. In Formula (A12-14), X 13 ' each independently represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group having 1 to 6 carbon atoms and containing a fluorine atom, or a phenyl group, and multiple X 13 ' groups may be the same or different. From the viewpoint of liquid crystal alignment, X 13 ′ preferably represents a hydrogen atom, a halogen atom, a methyl group, or an ethyl group, and more preferably represents a hydrogen atom or a methyl group.
在一些具體例中,前述之式(A12-5)與式(A12-6)可包含但不限於如下所示之結構。 In some specific examples, the aforementioned formula (A12-5) and formula (A12-6) may include but are not limited to the structures shown below.
前述之其他四羧酸二酐(a1-2)可單獨一種使用或混合複數種使用。The aforementioned other tetracarboxylic dianhydrides (a1-2) may be used alone or in combination of two or more.
基於四羧酸二酐組份(a1)的總使用量為100莫耳,其他四羧酸二酐(a1-2)的使用量為0莫耳至70莫耳,較佳為0莫耳至60莫耳,且更佳為0莫耳至50莫耳。Based on a total usage amount of 100 mol of the tetracarboxylic dianhydride component (a1), the usage amount of the other tetracarboxylic dianhydride (a1-2) is 0 mol to 70 mol, preferably 0 mol to 60 mol, and more preferably 0 mol to 50 mol.
二胺組份(a2)Diamine component (a2)
二胺組份(a2)可包含如式(A21)所示之二胺化合物(a2-1)與如式(A22)所示之二胺化合物(a2-2)。另外,二胺組份(a2)可選擇性地包含下述之二胺化合物(a2-3)、其他二胺化合物(a2-4),或上述化合物之任意組合。二胺組份(a2)可單獨使用一種或混合複數種使用。The diamine component (a2) may include a diamine compound (a2-1) represented by formula (A21) and a diamine compound (a2-2) represented by formula (A22). Furthermore, the diamine component (a2) may optionally include the following diamine compound (a2-3), other diamine compounds (a2-4), or any combination thereof. The diamine component (a2) may be used singly or in combination of multiple types.
二胺化合物(a2-1)Diamine compound (a2-1)
二胺化合物(a2-1)可具有如下式(A21)所示之結構。 (A21) The diamine compound (a2-1) may have a structure represented by the following formula (A21). (A21)
於式(A21)中,A 1和A 2代表二價之芳香環基團,且環部分可以具有取代基,其中A 1和A 2是相同的;Y 11代表 ,且R 1代表受熱而脫離的基團;Y 12代表單鍵、氧原子或硫原子;Z 1代表具有鏈狀烴結構和脂環烴結構的至少一者且碳數為1至15之二價有機基團,其中當Y 12代表硫原子時,Z 1所代表之二價有機基團之碳數不小於2。 In formula (A21), A1 and A2 represent a divalent aromatic cyclic group, and the cyclic portion may have a substituent, wherein A1 and A2 are the same; Y11 represents , and R 1 represents a group that is thermally dissociated; Y 12 represents a single bond, an oxygen atom, or a sulfur atom; Z 1 represents a divalent organic group having at least one of a chain hydrocarbon structure and an alicyclic hydrocarbon structure and having a carbon number of 1 to 15, wherein when Y 12 represents a sulfur atom, the carbon number of the divalent organic group represented by Z 1 is not less than 2.
於式(A21)中,A 1及A 2為自芳香環的環部分去除二個氫原子而成的基團,且亦可於環部分具有取代基。做為芳香環,例如可列舉:苯環、萘環(naphthalene ring)、蒽環(anthracene ring)、聯苯環(biphenyl ring)等之芳香族烴環;以及吡啶環、嘧啶環、吡嗪環(pyrazine ring)、噠嗪環(pyridazine ring)之含氮雜環。芳香環所具有的取代基可例如碳數為1至6的烷基。當A 1及A 2為相同時,有助於簡便地進行合成,以製備聚合物(A)。 In formula (A21), A1 and A2 are groups formed by removing two hydrogen atoms from an aromatic ring, and the ring portion may also have a substituent. Examples of aromatic rings include aromatic hydrocarbon rings such as a benzene ring, a naphthalene ring, an anthracene ring, and a biphenyl ring; and nitrogen-containing heterocyclic rings such as a pyridine ring, a pyrimidine ring, a pyrazine ring, and a pyridazine ring. Substituents on the aromatic rings may be, for example, alkyl groups having 1 to 6 carbon atoms. When A1 and A2 are the same, this facilitates simple synthesis to prepare polymer (A).
較佳地,A 1及A 2可為苯環、聯苯環、吡啶環或嘧啶環的環部分去除二個氫原子而成的基團,以獲得可降低液晶顯示元件之驅動後亮度變化率的液晶配向劑。 Preferably, A1 and A2 can be groups formed by removing two hydrogen atoms from a benzene ring, a biphenyl ring, a pyridine ring, or a pyrimidine ring, so as to obtain a liquid crystal alignment agent that can reduce the brightness change rate of a liquid crystal display device after driving.
於式(A21)中,Y 11代表 ,且R 1代表受熱而脫離的基團;Y 12代表單鍵、氧原子或硫原子。R 1代表之保護基較佳可例如為胺基甲酸酯系保護基、醯胺系保護基、醯亞胺系保護基或磺醯胺系保護基。R 1代表之保護基可具有如下式(A21'-1)所示之結構,且前述保護基是高熱離去性基團,故可有效減少去保護部分於液晶配向膜中之殘留量。 (A21'-1) In formula (A21), Y 11 represents , and R 1 represents a group that releases upon heating; Y 12 represents a single bond, an oxygen atom, or a sulfur atom. The protecting group represented by R 1 is preferably a carbamate protecting group, an amide protecting group, an imide protecting group, or a sulfonamide protecting group. The protecting group represented by R 1 may have the structure shown in the following formula (A21'-1). The aforementioned protecting group is a highly heat-releasing group, thereby effectively reducing the amount of residual deprotected moieties in the liquid crystal alignment film. (A21'-1)
於式(A21'-1)中,Y 1代表單鍵或碳數為1至4的二價烴基基團。 In formula (A21'-1), Y1 represents a single bond or a divalent alkyl group having 1 to 4 carbon atoms.
於式(A21)中,Z 1代表具有碳數為1至15的鏈狀烴結構或碳數為3至15的脂環式烴結構之二價有機基團。其中,所述之「鏈狀烴結構」是指不含環狀結構而僅包含鏈狀結構的直鏈狀烴結構及支鏈狀烴結構。鏈狀烴結構可為飽和,亦可為不飽和。所述之「脂環式烴結構」是指僅包含以脂環式烴的結構做為環結構,而不含芳香環結構的烴結構。脂環式烴結構不限於僅包含脂環式烴的結構,其一部分亦可包含鏈狀結構。 In formula (A21), Z1 represents a divalent organic group having a chain hydrocarbon structure with a carbon number of 1 to 15 or an alicyclic hydrocarbon structure with a carbon number of 3 to 15. The "chain hydrocarbon structure" refers to a linear hydrocarbon structure and a branched hydrocarbon structure that do not contain a ring structure but only contain a chain structure. The chain hydrocarbon structure may be saturated or unsaturated. The "alicyclic hydrocarbon structure" refers to a hydrocarbon structure that only contains alicyclic hydrocarbon structures as ring structures and does not contain aromatic ring structures. The alicyclic hydrocarbon structure is not limited to a structure containing only alicyclic hydrocarbons, and a portion thereof may also contain a chain structure.
較佳地,於式(A21)中,當A 1與A 2代表自苯環、吡啶環或嘧啶環的環部分去除二個氫原子而成的二價基團,其中環部分可以具有取代基,且A 1和A 2是相同的;而Z 1代表 ,且n代表1至5之整數時,利用此液晶配向劑所製得之液晶配向膜可進一步降低液晶顯示元件的驅動後亮度變化率。 Preferably, in formula (A21), when A1 and A2 represent a divalent group formed by removing two hydrogen atoms from a ring portion of a benzene ring, a pyridine ring or a pyrimidine ring, wherein the ring portion may have a substituent, and A1 and A2 are the same; and Z1 represents , and when n represents an integer from 1 to 5, the liquid crystal alignment film prepared using this liquid crystal alignment agent can further reduce the brightness change rate of the liquid crystal display element after driving.
基於降低驅動後亮度變化率之觀點,相對於式(A21)中的氮原子,式(A21)中的A 1與A 2所代表之苯環、吡啶環或嘧啶環上的鍵結位置較佳為對位。上述式(A21)所示的二胺化合物(a2-1)較佳可為如下式(A21'-2)所示的二胺化合物。 (A21'-2) From the perspective of reducing the brightness change rate after driving, the bonding position of the benzene ring, pyridine ring, or pyrimidine ring represented by A1 and A2 in formula (A21) is preferably para relative to the nitrogen atom in formula (A21). The diamine compound (a2-1) represented by formula (A21) is preferably a diamine compound represented by the following formula (A21'-2). (A21'-2)
於式(A21'-2)中,Q 1及Q 2分別獨立地代表-CH-或氮原子;Y 11與Y 12之定義如前所述;m 1代表1至5之整數。 In formula (A21'-2), Q1 and Q2 independently represent -CH- or a nitrogen atom; Y11 and Y12 are as defined above; and m1 represents an integer from 1 to 5.
在一些具體例中,本發明之二胺化合物(a2-1)可包含但不限於如下式(A21-1)至式(A21-11)所示的化合物。二胺化合物(a2-1)的具體化合物可藉由適合的組合有機化學的通用方法來合成。所述之二胺化合物(a2-1)可單獨一種使用,或混合複數種使用。於下式(A21-1)至(A21-11)中,R b代表第三丁氧基羰基(t-butyloxy carbonyl)。 (A21-1) (A21-2) (A21-3) (A21-4) (A21-5) (A21-6) (A21-7) (A21-8) (A21-9) (A21-10) (A21-11) In some specific examples, the diamine compound (a2-1) of the present invention may include, but is not limited to, compounds represented by the following formulas (A21-1) to (A21-11). The specific compounds of the diamine compound (a2-1) can be synthesized by suitable general methods of combinatorial organic chemistry. The diamine compound (a2-1) may be used alone or in combination of multiple compounds. In the following formulas (A21-1) to (A21-11), R represents a t-butyloxycarbonyl group. (A21-1) (A21-2) (A21-3) (A21-4) (A21-5) (A21-6) (A21-7) (A21-8) (A21-9) (A21-10) (A21-11)
基於二胺組分(a2)的使用量為100莫耳,如式(A21)所示之二胺化合物(a2-1)的總使用量為1莫耳至20莫耳,較佳為2莫耳至15莫耳,且更佳為3莫耳至10莫耳。Based on 100 mol of the diamine component (a2), the total amount of the diamine compound (a2-1) represented by formula (A21) is 1 mol to 20 mol, preferably 2 mol to 15 mol, and more preferably 3 mol to 10 mol.
若聚合物(A)之二胺組份(a2)不包含如式(A21)所示之二胺化合物(a2-1)時,含有此液晶配向劑所形成之液晶配向膜的液晶顯示單元之驅動後亮度變化率不佳。If the diamine component (a2) of the polymer (A) does not contain the diamine compound (a2-1) represented by formula (A21), the liquid crystal alignment film formed with the liquid crystal alignment agent has a poor brightness change rate after driving.
二胺化合物(a2-2)Diamine compound (a2-2)
二胺化合物(a2-2)可具有如下式(A22)所示之結構。 (A22) The diamine compound (a2-2) may have a structure represented by the following formula (A22). (A22)
於式(A22)中,Y 21代表單鍵、-O-、-S-、-S-S-、-SO 2-、-CO-、 、 、-C(CH 3) 2-、-C(CF 3) 2-、-(CH 2) m-、-O-(CH 2) m-O-或-S-(CH 2) m-S-,且m代表1至12之整數;且Y 22代表單鍵、-O-、-S-、-CO-、-C(CH 3) 2-、-C(CF 3) 2-或碳數為1至10之伸烷基。 In formula (A22), Y 21 represents a single bond, -O-, -S-, -SS-, -SO 2 -, -CO-, 、 , -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -(CH 2 ) m -, -O-(CH 2 ) m -O-, or -S-(CH 2 ) m -S-, and m represents an integer from 1 to 12; and Y 22 represents a single bond, -O-, -S-, -CO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, or an alkylene group having 1 to 10 carbon atoms.
於式(A22)中,苯環的氫原子可被-F、-CH 3、-OH、-CF 3或芐基所取代或未被取代;鍵結位置未固定於構成苯環的任何碳原子上之基團代表其於苯環之鍵結位置是任意的;而-NH 2與苯環之鍵結位置係除Y 21或Y 22之鍵結位置以外的任意位置。較佳地,Y 21與Y 22分別獨立地代表-O-或-S-。當Y 21與Y 22分別獨立地代表-O-或-S-時,利用此液晶配向劑所製得之液晶配向膜可更進一步降低液晶顯示元件的驅動後亮度變化率。 In formula (A22), the hydrogen atom of the benzene ring may or may not be substituted with -F, -CH 3 , -OH, -CF 3 , or benzyl. A group whose bonding position is not fixed to any carbon atom constituting the benzene ring represents that its bonding position on the benzene ring is arbitrary. The bonding position of -NH 2 to the benzene ring is any position other than the bonding position of Y 21 or Y 22 . Preferably, Y 21 and Y 22 each independently represent -O- or -S-. When Y 21 and Y 22 each independently represent -O- or -S-, the liquid crystal alignment film produced using this liquid crystal alignment agent can further reduce the brightness change rate of the liquid crystal display device after driving.
在一些具體例中,如式(A22)所示之二胺化合物(a2-2)可包含但不限於如下式(A22-1)至式(A22-7)所示之化合物。 (A22-1) (A22-2) (A22-3) (A22-4) (A22-5) (A22-6) (A22-7) In some specific examples, the diamine compound (a2-2) represented by formula (A22) may include but is not limited to compounds represented by the following formulas (A22-1) to (A22-7). (A22-1) (A22-2) (A22-3) (A22-4) (A22-5) (A22-6) (A22-7)
上述之二胺化合物(a2-2)可單獨一種使用或混合複數種使用。The above-mentioned diamine compound (a2-2) may be used alone or in combination of two or more.
基於二胺組份(a2)之總使用量為100莫耳,二胺化合物(a2-2)的使用量可為10莫耳至60莫耳,較佳為12莫耳至50莫耳,且更佳為15莫耳至40莫耳。Based on 100 mol of the total usage of the diamine component (a2), the usage of the diamine compound (a2-2) can be 10 mol to 60 mol, preferably 12 mol to 50 mol, and more preferably 15 mol to 40 mol.
若二胺組份(a2)不包含如式(A22)所示之二胺化合物(a2-2)時,含有此液晶配向劑所形成之液晶配向膜的液晶顯示單元之驅動後亮度變化率不佳。If the diamine component (a2) does not contain the diamine compound (a2-2) represented by formula (A22), the liquid crystal alignment film formed by the liquid crystal alignment agent has a poor brightness change rate after driving.
二胺化合物(a2-3)Diamine compound (a2-3)
二胺化合物(a2-3)可包含如下式(A23-1)或式(A23-2)所示之二胺化合物。 (A23-1) (A23-2) The diamine compound (a2-3) may include a diamine compound represented by the following formula (A23-1) or formula (A23-2). (A23-1) (A23-2)
於式(A23-1)中,Y 31代表如下式(A23-3)所示之二價有機基團。複數個Y 32分別獨立地代表氫原子或碳數為1至6之烷基。於式(A23-2)中,複數個Y 33分別獨立地代表如下式(A23-3')所示之二價有機基團。 (A23-3) (A23-3') In formula (A23-1), Y 31 represents a divalent organic group as shown in formula (A23-3) below. Plural Y 32 groups independently represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. In formula (A23-2), plural Y 33 groups independently represent a divalent organic group as shown in formula (A23-3') below. (A23-3) (A23-3')
於式(A23-3)中,Ar分別獨立地代表二價之苯環、聯苯結構或萘環,且苯環、聯苯結構或萘環之氫原子可被一價取代基團所取代或未被取代;Y 31'代表-(CH 2) n-,n代表2至18之整數,且-(CH 2) n-中的至少一個-CH 2-可被-O-、-C(=O)-或-O-C(=O)-所取代或未被取代;p1代表0或1之整數;「*」代表鍵結位置。 In formula (A23-3), Ar independently represents a divalent benzene ring, a biphenyl structure, or a naphthyl ring, and the hydrogen atom of the benzene ring, biphenyl structure, or naphthyl ring may or may not be substituted by a monovalent substituent group; Y 31 ' represents -(CH 2 ) n -, n represents an integer from 2 to 18, and at least one -CH 2 - in -(CH 2 ) n - may or may not be substituted by -O-, -C(═O)-, or -OC(═O)-; p1 represents an integer of 0 or 1; and "*" represents a bonding position.
於式(A23-3')中,Ar'分別獨立地代表二價之苯環或聯苯結構,且苯環或聯苯結構之氫原子可被一價取代基團所取代或未被取代;Y 33'代表-(CH 2) n-,n代表2至18之整數,且-(CH 2) n-中的至少一個-CH 2-可被-O-、-C(=O)-或-O-C(=O)-所取代或未被取代;p2代表0或1之整數;「*」代表鍵結位置。 In formula (A23-3'), Ar' independently represents a divalent benzene ring or a biphenyl structure, and the hydrogen atom of the benzene ring or biphenyl structure may or may not be substituted by a monovalent substituent group; Y 33 ' represents -(CH 2 ) n -, n represents an integer from 2 to 18, and at least one -CH 2 - in -(CH 2 ) n - may or may not be substituted by -O-, -C(=O)-, or -OC(=O)-; p2 represents an integer of 0 or 1; and "*" represents a bonding position.
前述苯環、聯苯結構、或萘環之一價取代基團可例如為鹵素原子、碳數為1至10之烷基、碳數為2至10之烯基、碳數為1至10之烷氧基、碳數為1至10之氟烷基、碳數為2至10之氟烯基、碳數為1至10之氟烷氧基、羧基、羥基、碳數為1至10之烷氧基羰基、氰基或硝基等。The monovalent substituent of the aforementioned benzene ring, biphenyl structure, or naphthyl ring may be, for example, a halogen atom, an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, a fluoroalkyl group having 1 to 10 carbon atoms, a fluoroalkenyl group having 2 to 10 carbon atoms, a fluoroalkoxy group having 1 to 10 carbon atoms, a carboxyl group, a hydroxyl group, an alkoxycarbonyl group having 1 to 10 carbon atoms, a cyano group, or a nitro group.
基於提高液晶配向性之觀點,式(A23-3)所示之二價有機基團較佳可包含如下式(A23-3-1)至式(A23-3-16)所示之基團,其中「*」代表鍵結位置。 (A23-3-1) (A23-3-2) (A23-3-3) (A23-3-4) (A23-3-5) (A23-3-6) (A23-3-7) (A23-3-8) (A23-3-9) (A23-3-10) (A23-3-11) (A23-3-12) (A23-3-13) (A23-3-14) (A23-3-15) (A23-3-16) From the perspective of improving the liquid crystal alignment, the divalent organic group represented by formula (A23-3) preferably includes groups represented by the following formulas (A23-3-1) to (A23-3-16), where "*" represents a bonding position. (A23-3-1) (A23-3-2) (A23-3-3) (A23-3-4) (A23-3-5) (A23-3-6) (A23-3-7) (A23-3-8) (A23-3-9) (A23-3-10) (A23-3-11) (A23-3-12) (A23-3-13) (A23-3-14) (A23-3-15) (A23-3-16)
於式(A23-3-14)中,複數個m分別獨立地代表1至3之整數。In formula (A23-3-14), each of the multiple m's independently represents an integer from 1 to 3.
基於提高液晶配向性之觀點,式(A23-3')所示之二價有機基團較佳可包含如式(A23-3-7)至式(A23-3-16)所示之基團。From the perspective of improving the liquid crystal alignment, the divalent organic group represented by formula (A23-3') preferably includes groups represented by formulas (A23-3-7) to (A23-3-16).
當二胺化合物(a2-3)包含複數個如式(A23-1)所示之二胺化合物時,其較佳為式(A23-1)中之Y 31代表式(A23-3-1)至式(A23-3-14)的二胺化合物與式(A23-1)中之Y 31代表式(A23-3-15)至式(A23-3-16)的二胺化合物之組合。 When the diamine compound (a2-3) contains a plurality of diamine compounds as represented by formula (A23-1), it is preferably a combination of a diamine compound in which Y 31 in formula (A23-1) represents a diamine compound of formula (A23-3-1) to formula (A23-3-14) and a diamine compound in which Y 31 in formula (A23-1) represents a diamine compound of formula (A23-3-15) to formula (A23-3-16).
在一些具體例中,前述式(A23-2)所示之二胺化合物可包含但不限於如下式(A23-2-1)至式(A23-2-5)所示之二胺化合物。 (A23-2-1) (A23-2-2) (A23-2-3) (A23-2-4) (A23-2-5) In some specific examples, the diamine compound represented by the aforementioned formula (A23-2) may include, but is not limited to, diamine compounds represented by the following formulas (A23-2-1) to (A23-2-5). (A23-2-1) (A23-2-2) (A23-2-3) (A23-2-4) (A23-2-5)
前述之二胺化合物(a2-3)可單獨一種使用或混合複數種使用。The aforementioned diamine compounds (a2-3) may be used alone or in combination of two or more.
基於二胺組份(a2)之總使用量為100莫耳,二胺化合物(a2-3)的使用量可為20莫耳至89莫耳,較佳為38莫耳至90莫耳,且更佳為50莫耳至87莫耳。Based on 100 mol of the total usage of the diamine component (a2), the usage of the diamine compound (a2-3) may be 20 mol to 89 mol, preferably 38 mol to 90 mol, and more preferably 50 mol to 87 mol.
其他二胺化合物(a2-4)Other diamine compounds (a2-4)
除前述如式(A21)所示之二胺化合物(a2-1)、如式(A22)所示之二胺化合物(a2-2)與二胺化合物(a2-3)外,用以獲得聚合物(A)之二胺組份(a2)可選擇性地包含其他二胺化合物(a2-4)。舉例而言,其他二胺化合物(a2-4)可包含但不限於:4,4'-二胺基偶氮苯或如下式(A24-1)至式(A24-3)所示之二胺化合物等具有光配向性基之二胺化合物;2,4-二胺基苯酚、3,5-二胺基苯酚、3,5-二胺基苯甲醇、2,4-二胺基苯甲醇或4,6-二胺基間苯二酚;2,4-二胺基苯甲酸、2,5-二胺基苯甲酸、3,5-二胺基苯甲酸或如下式(A24-4)至式(A24-7)所示之二胺化合物等具有羧基之二胺化合物;3,3'-二胺基二苯基甲烷、4,4'-二胺基二苯基甲烷、3,4'-二胺基二苯基甲烷、4,4'-二胺基二苯基酮、1,4-雙(4-胺基苄基)苯、4,4'-二胺基二苯醚、1-(4-胺基苯基)-1,3,3-三甲基-1H-二氫茚-5-胺或1-(4-胺基苯基)-2,3-二氫-1,3,3-三甲基-1H-茚-6-胺;如下式(A24-8)至式(A24-10)所示之二胺化合物等具有脲鍵之二胺化合物;如下式(A24-11)至式(A24-13)所示之具有醯胺鍵之二胺化合物;甲基丙烯酸2-(2,4-二胺基苯氧基)乙基或2,4-二胺基-N,N-二烯丙基苯胺等末端有光聚合性基之二胺化合物;如下式(A24-14)至式(A24-15)所示之二胺化合物等具㗁唑啉結構之二胺化合物。 (A24-1) (A24-2) (A24-3) (A24-4) (A24-5) (A24-6) (A24-7) (A24-8) (A24-9) (A24-10) (A24-11) (A24-12) (A24-13) (A24-14) (A24-15) In addition to the aforementioned diamine compound (a2-1) represented by formula (A21), the diamine compound (a2-2) represented by formula (A22), and the diamine compound (a2-3), the diamine component (a2) used to obtain the polymer (A) may optionally include another diamine compound (a2-4). For example, other diamine compounds (a2-4) may include, but are not limited to: 4,4'-diaminoazobenzene or diamine compounds represented by the following formulas (A24-1) to (A24-3), such as diamine compounds having a photoalignment group; 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, or 4,6-diaminoresorcinol; 2,4-diaminobenzoic acid, 2,5-diaminobenzoic acid, 3,5-diaminobenzoic acid, or diamine compounds represented by the following formulas (A24-4) to (A24-7), such as diamine compounds having a carboxyl group; 3,3'-diaminodiphenylmethane, 4,4'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ketone, 1,4-diaminodiphenyl ketone, (4-aminobenzyl)benzene, 4,4'-diaminodiphenyl ether, 1-(4-aminophenyl)-1,3,3-trimethyl-1H-dihydroindene-5-amine or 1-(4-aminophenyl)-2,3-dihydro-1,3,3-trimethyl-1H-indene-6-amine; diamine compounds having a urea bond, such as diamine compounds represented by the following formulas (A24-8) to (A24-10); Diamine compounds having an amide bond represented by formula (A24-11) to formula (A24-13); diamine compounds having a photopolymerizable group at the end, such as 2-(2,4-diaminophenoxy)ethyl methacrylate or 2,4-diamino-N,N-diallylaniline; and diamine compounds having an oxazoline structure, such as the diamine compounds represented by formula (A24-14) to formula (A24-15). (A24-1) (A24-2) (A24-3) (A24-4) (A24-5) (A24-6) (A24-7) (A24-8) (A24-9) (A24-10) (A24-11) (A24-12) (A24-13) (A24-14) (A24-15)
於式(A24-4)中,Y 41表示單鍵、-CH 2-、-C 2H 4-、-C(CH 3) 2-、-CF 2-、-C(CF 3) 2-、-O-、-CO-、-NH-、-N(CH 3)-、-CONH-、-NHCO-、-CH 2O-、-OCH 2-、-COO-、-OCO-、-CON(CH 3)-或-N(CH 3)CO-;m1及m2分別獨立地代表0至4之整數,且(m1+m2)代表1至4之整數。於式(A24-5)中,m3及m4分別獨立地代表1至5之整數。於式(A24-6)中,Y 42表示碳數為1至5之直鏈或支鏈烷基;m5表示1至5之整數。於式(A24-7)中,Y 43及Y 44分別獨立地代表單鍵、-CH 2-、-C 2H 4-、-C(CH 3) 2-、-CF 2-、-C(CF 3) 2-、-O-、-CO-、-NH-、-N(CH 3)-、-CONH-、-NHCO-、-CH 2O-、-OCH 2-、-COO-、-OCO-、-CON(CH 3)-或-N(CH 3)CO-;m6表示1至4之整數。 In formula (A24-4), Y41 represents a single bond, -CH2- , -C2H4-, -C(CH3) 2- , -CF2- , -C( CF3 ) 2- , -O-, -CO-, -NH-, -N( CH3 ) - , -CONH-, -NHCO-, -CH2O-, -OCH2-, -COO-, -OCO- , -CON( CH3 ) -, or -N( CH3 )CO-; m1 and m2 each independently represent an integer from 0 to 4, and (m1+m2) represents an integer from 1 to 4. In formula (A24-5), m3 and m4 each independently represent an integer from 1 to 5. In formula (A24-6), Y42 represents a linear or branched alkyl group having 1 to 5 carbon atoms; m5 represents an integer from 1 to 5. In formula (A24-7), Y43 and Y44 each independently represent a single bond, -CH2- , -C2H4- , -C( CH3 ) 2- , -CF2- , -C( CF3 ) 2- , -O-, -CO- , -NH-, -N( CH3 )-, -CONH-, -NHCO-, -CH2O- , -OCH2- , -COO-, -OCO-, -CON( CH3 )-, or -N( CH3 )CO-; m6 represents an integer from 1 to 4.
前述之其他二胺化合物(a2-4)可單獨一種使用或混合複數種使用。The aforementioned other diamine compounds (a2-4) may be used alone or in combination of two or more.
基於二胺組份(a2)之總使用量為100莫耳,其他二胺化合物(a2-4)的使用量可為0莫耳至80莫耳,較佳為0莫耳至60莫耳,且更佳為0莫耳至40莫耳。Based on a total usage amount of 100 mol of the diamine component (a2), the usage amount of the other diamine compounds (a2-4) may be 0 mol to 80 mol, preferably 0 mol to 60 mol, and more preferably 0 mol to 40 mol.
聚合物(B)Polymer (B)
除前述之聚合物(A)外,本發明之液晶配向劑也可選擇性地含有選自於由使用四羧酸二酐組份(b1)及二胺組份(b2)獲得之聚醯亞胺前驅物,以及此聚醯亞胺前驅物之醯亞胺化聚合物(即聚醯亞胺)所組成之群組中的聚合物(B)。舉例而言,聚合物(B)可例如包含但不限於選自於由使用四羧酸二酐組份(b1)及不含上述特定二胺化合物(如二胺化合物(a2-1)與二胺化合物(a2-2))之二胺組份(b2)所獲得之聚醯亞胺前驅物及此聚醯亞胺前驅物之醯亞胺化物(即聚醯亞胺)所組成之群組中的至少一種聚合物。上述聚醯亞胺前驅物之具體例可例如包含聚醯胺酸或聚醯胺酸酯等。所述之聚合物(B)可單獨一種使用,也可混合複數種使用。In addition to the aforementioned polymer (A), the liquid crystal alignment agent of the present invention may optionally contain a polymer (B) selected from the group consisting of a polyimide precursor obtained using a tetracarboxylic dianhydride component (b1) and a diamine component (b2), and an imidized polymer of such a polyimide precursor (i.e., a polyimide). For example, polymer (B) may include, but is not limited to, at least one polymer selected from the group consisting of a polyimide precursor obtained using a tetracarboxylic dianhydride component (b1) and a diamine component (b2) that does not contain the aforementioned specific diamine compounds (e.g., diamine compound (a2-1) and diamine compound (a2-2)), and an imidized polymer of such a polyimide precursor (i.e., a polyimide). Specific examples of the polyimide precursor include polyamic acid or polyamic acid ester, etc. The polymer (B) may be used alone or in combination of two or more.
聚合物(A)與聚合物(B)之用量比例(即[聚合物(A)]/[聚合物(B)]的質量比)可為10/90至90/10,較佳為20/80至90/10,且更佳為20/80至80/20。The ratio of polymer (A) to polymer (B) (i.e., the mass ratio of [polymer (A)]/[polymer (B)]) can be 10/90 to 90/10, preferably 20/80 to 90/10, and more preferably 20/80 to 80/20.
四羧酸二酐組份(b1)Tetracarboxylic dianhydride component (b1)
用以獲得聚合物(B)之四羧酸二酐組份(b1)可例如包含但不限於非環族脂肪族四羧酸二酐化合物、脂環族四羧酸二酐化合物、芳香族四羧酸二酐化合物,或此些化合物之衍生物。非環族脂肪族四羧酸二酐化合物、脂環族四羧酸二酐化合物與芳香族四羧酸二酐化合物之具體例可例如包含前述聚合物(A)所例示之四羧酸二酐化合物。較佳地,四羧酸二酐組份(b1)可包含如上式(A11)所示之脂環族四羧酸二酐或其衍生物,或者如上式(A12)所示且X 1'代表式(A12-1)至式(A12-6)所示之結構的四羧酸二酐化合物或其衍生物。所述之四羧酸二酐組份(b1)可單獨一種使用或混合複數種使用。 The tetracarboxylic dianhydride component (b1) used to obtain the polymer (B) may include, but is not limited to, a non-cyclic aliphatic tetracarboxylic dianhydride compound, an alicyclic tetracarboxylic dianhydride compound, an aromatic tetracarboxylic dianhydride compound, or derivatives of these compounds. Specific examples of the non-cyclic aliphatic tetracarboxylic dianhydride compound, the alicyclic tetracarboxylic dianhydride compound, and the aromatic tetracarboxylic dianhydride compound may include, for example, the tetracarboxylic dianhydride compounds exemplified for the polymer (A). Preferably, the tetracarboxylic dianhydride component (b1) may include an alicyclic tetracarboxylic dianhydride or a derivative thereof as represented by the above formula (A11), or a tetracarboxylic dianhydride compound or a derivative thereof as represented by the above formula (A12) where X 1 ' represents a structure represented by formula (A12-1) to formula (A12-6). The tetracarboxylic dianhydride component (b1) may be used alone or in combination of a plurality of types.
基於更進一步降低驅動後亮度變化率之觀點,四羧酸二酐組份(b1)較佳包含如上式(A12)所示且X 1'代表下式(III)所示之結構的四羧酸二酐化合物 (後述將其稱之為四羧酸二酐化合物(b1-1))。 (III) To further reduce the brightness change rate after driving, the tetracarboxylic dianhydride component (b1) preferably includes a tetracarboxylic dianhydride compound represented by formula (A12) above and wherein X 1 ' represents a structure represented by formula (III) below (hereinafter referred to as tetracarboxylic dianhydride compound (b1-1)). (III)
於式(III)中,Z 11代表單鍵;且「*」代表鍵結位置。 In formula (III), Z 11 represents a single bond; and “*” represents a bonding position.
前述之四羧酸二酐化合物(b1-1)可單獨一種使用或混合複數種使用。The aforementioned tetracarboxylic dianhydride compound (b1-1) may be used alone or in combination of two or more.
更佳地,四羧酸二酐組份(b1)包含如下式(IV)所示之四羧酸二酐化合物。 (IV) More preferably, the tetracarboxylic dianhydride component (b1) comprises a tetracarboxylic dianhydride compound represented by the following formula (IV). (IV)
基於四羧酸二酐組份(b1)之總使用量為100莫耳,四羧酸二酐化合物(b1-1)的使用量可為30莫耳至100莫耳,較佳為40莫耳至100莫耳,且更佳為50莫耳至100莫耳。Based on the total usage of the tetracarboxylic dianhydride component (b1) being 100 mol, the usage of the tetracarboxylic dianhydride compound (b1-1) can be 30 mol to 100 mol, preferably 40 mol to 100 mol, and more preferably 50 mol to 100 mol.
若四羧酸二酐組份(b1)包含四羧酸二酐化合物(b1-1)時,含有此液晶配向劑所形成之液晶配向膜的液晶顯示單元可具有更佳之驅動後亮度變化率。If the tetracarboxylic dianhydride component (b1) includes the tetracarboxylic dianhydride compound (b1-1), the liquid crystal alignment film formed with the liquid crystal alignment agent can have a better brightness change rate after driving.
二胺組份(b2)Diamine component (b2)
用以獲得聚合物(B)之二胺組份(b2)可例如包含但不限於前述之二胺組份(a2),或者具有選自於由含氮原子之雜環、二級胺基與三級胺基所構成之群組中之至少一種含氮原子結構的二胺化合物(後述將其稱之為二胺化合物(b2-1)),但二胺組份(b2)不包含前述之二胺化合物(a2-1)和二胺化合物(a2-2)。The diamine component (b2) used to obtain the polymer (B) may include, but is not limited to, the aforementioned diamine component (a2), or a diamine compound having at least one nitrogen-containing structure selected from the group consisting of a nitrogen-containing heterocyclic ring, a diamine group, and a tertiary amine group (hereinafter referred to as the diamine compound (b2-1)). However, the diamine component (b2) does not include the aforementioned diamine compound (a2-1) and diamine compound (a2-2).
所述之二胺組份(b2)可單獨一種使用或混合複數種使用。The diamine component (b2) may be used alone or in combination of two or more.
二胺化合物(b2-1)Diamine compound (b2-1)
具有上述特定之含氮原子結構之二胺化合物(b2-1)可具有含氮原子之雜環,例如:吡咯、咪唑、吡唑、三唑、吡啶、嘧啶、嗒 、吡 、吲哚、苯并咪唑、嘌呤、喹啉、異喹啉、㖠啶、喹㗁啉、呔 、三 、咔唑、吖啶、哌啶、哌 、吡咯啶或六亞甲基亞胺等。其中,吡啶、嘧啶、吡 、哌啶、哌 、喹啉、咔唑或吖啶為較佳。 The diamine compound (b2-1) having the above-mentioned specific nitrogen-containing atom structure may have a nitrogen-containing heterocyclic ring, such as pyrrole, imidazole, pyrazole, triazole, pyridine, pyrimidine, pyrimidine, pyr ... pyridine , indole, benzimidazole, purine, quinoline, isoquinoline, oxadiazole, quinoline, pyridine ,three , carbazole, acridine, piperidine, piperidine , pyrrolidine or hexamethyleneimine, etc. Among them, pyridine, pyrimidine, pyrrolidine, , piperidine, piperidine , quinoline, carbazole or acridine is preferred.
具有上述特定之含氮原子結構之二胺化合物(b2-1)可包含如下式(B21)所示之二級胺基及三級胺基。 (B21) The diamine compound (b2-1) having the above-mentioned specific nitrogen-containing structure may include a diamine group and a tertiary amine group as represented by the following formula (B21). (B21)
於式(B21)中,Z代表氫原子或碳數為1至10之烷基、環烷基或芳基;「*」代表鍵結烴基的鍵結位置。In formula (B21), Z represents a hydrogen atom or an alkyl group, cycloalkyl group, or aryl group having 1 to 10 carbon atoms; "*" represents the bonding position to the alkyl group.
前述Z所代表之烷基可例如包含但不限於甲基、乙基或丙基;所代表之環烷基可例如包含但不限於環己基;所代表之芳基可例如包含但不限於苯基或甲苯基。Z較佳為氫原子或甲基。The alkyl group represented by Z may include, but is not limited to, methyl, ethyl, or propyl; the cycloalkyl group represented by Z may include, but is not limited to, cyclohexyl; and the aryl group represented by Z may include, but is not limited to, phenyl or tolyl. Z is preferably a hydrogen atom or a methyl group.
具有上述特定之含氮原子結構的二胺化合物(b2-1)之具體例可例如包含:2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嘧啶、3,6-二胺基咔唑、N-甲基-3,6-二胺基咔唑、1,4-雙-(4-胺基苯基)-哌 、3,6-二胺基吖啶、N-乙基-3,6-二胺基咔唑、N-苯基-3,6-二胺基咔唑、如下式(B21-1)至式(B21-8)所示之二胺化合物,或如下式(B21-9)至式(B21-26)所示之二胺化合物。 (B21-1) (B21-2) (B21-3) (B21-4) (B21-5) (B21-6) (B21-7) (B21-8) (B21-9) (B21-10) (B21-11) (B21-12) (B21-13) (B21-14) (B21-15) (B21-16) (B21-17) (B21-18) (B21-19) (B21-20) (B21-21) (B21-22) (B21-23) (B21-24) (B21-25) (B21-26) Specific examples of the diamine compound (b2-1) having the above-mentioned specific nitrogen-containing atom structure include: 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, 1,4-bis-(4-aminophenyl)-piperidin , 3,6-diaminoacridine, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, diamine compounds represented by the following formulas (B21-1) to (B21-8), or diamine compounds represented by the following formulas (B21-9) to (B21-26). (B21-1) (B21-2) (B21-3) (B21-4) (B21-5) (B21-6) (B21-7) (B21-8) (B21-9) (B21-10) (B21-11) (B21-12) (B21-13) (B21-14) (B21-15) (B21-16) (B21-17) (B21-18) (B21-19) (B21-20) (B21-21) (B21-22) (B21-23) (B21-24) (B21-25) (B21-26)
所述之二胺化合物(b2-1)可單獨一種使用或混合複數種使用。The diamine compound (b2-1) may be used alone or in combination of two or more.
基於二胺組份(b2)之總使用量為100莫耳,二胺化合物(b2-1)的使用量可為15莫耳至100莫耳,較佳為20莫耳至90莫耳,且更佳為25莫耳至80莫耳。Based on 100 mol of the total usage of the diamine component (b2), the usage of the diamine compound (b2-1) can be 15 mol to 100 mol, preferably 20 mol to 90 mol, and more preferably 25 mol to 80 mol.
若二胺組份(b2)包含二胺化合物(b2-1)時,利用此液晶配向劑所製得之液晶配向膜可進一步降低液晶顯示元件的驅動後亮度變化率。If the diamine component (b2) includes the diamine compound (b2-1), the liquid crystal alignment film prepared using this liquid crystal alignment agent can further reduce the brightness change rate of the liquid crystal display device after driving.
聚合物的製作方法Polymer production method
聚合物(A)或聚合物(B)之製造可藉由使前述之二胺組份和四羧酸二酐組份於溶劑中進行(縮聚合)反應來進行。當聚合物(A)或聚合物(B)之一部分具有醯胺酸結構時,例如藉由使四羧酸二酐組份與二胺組份反應,以獲得具有醯胺酸結構之聚合物(即聚醯胺酸)。前述之溶劑沒有特別之限制,其僅須可溶解所形成之聚合物即可。舉例而言,溶劑之具體例可包含但不限於N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、γ-丁內酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、二甲基亞碸或1,3-二甲基-2-咪唑啶酮。在一些具體例中,當聚合物之溶劑溶解性較高時,溶劑可包含甲乙酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮,或如下式(D-1)至式(D-3)所示之溶劑。於式(D-1)中,Z 1代表碳數為1至3之烷基。於式(D-2)中,Z 2代表碳數為1至3之烷基。於式(D-3)中,Z 3代表示碳數為1至4之烷基。 (D-1) (D-2) (D-3) The production of polymer (A) or polymer (B) can be carried out by reacting the aforementioned diamine component and tetracarboxylic dianhydride component in a solvent (polycondensation). When a portion of polymer (A) or polymer (B) has an acylamidic acid structure, for example, by reacting the tetracarboxylic dianhydride component with the diamine component, a polymer having an acylamidic acid structure (i.e., polyacylamidic acid) can be obtained. The aforementioned solvent is not particularly limited; it only needs to be able to dissolve the formed polymer. For example, specific examples of the solvent may include, but are not limited to, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, γ-butyrolactone, N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulfoxide, or 1,3-dimethyl-2-imidazolidinone. In some embodiments, when the polymer has high solvent solubility, the solvent may include methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone, or solvents represented by Formulas (D-1) to (D-3) below. In Formula (D-1), Z 1 represents an alkyl group having 1 to 3 carbon atoms. In Formula (D-2), Z 2 represents an alkyl group having 1 to 3 carbon atoms. In Formula (D-3), Z 3 represents an alkyl group having 1 to 4 carbon atoms. (D-1) (D-2) (D-3)
前述之溶劑可單獨一種使用,或混合複數種使用。其次,縱使是無法溶解聚合物之溶劑,其仍可在所生成之聚合物不會析出的範圍內,與上述之溶劑混合使用。當二胺組份與四羧酸二酐組份在溶劑中反應時,反應能以任意之濃度來進行,但較佳為1 wt%至50 wt%,且更佳為5 wt%至30 wt%。反應初始亦可於高濃度進行,之後再額外添加溶劑。進行反應時,二胺組份之總莫耳數與四羧酸二酐組份之總莫耳數的比值較佳為0.8至1.2。相同於一般之縮聚反應,此莫耳比值越接近1.0時,所形成之聚合物(A)或聚合物(B)的分子量越大。The aforementioned solvents can be used alone or in combination. Secondly, even if the solvent cannot dissolve the polymer, it can still be mixed with the above-mentioned solvents within the range that the generated polymer will not precipitate. When the diamine component and the tetracarboxylic dianhydride component react in the solvent, the reaction can be carried out at any concentration, but preferably 1 wt% to 50 wt%, and more preferably 5 wt% to 30 wt%. The reaction can also be carried out at a high concentration initially, and then additional solvent is added. During the reaction, the ratio of the total molar number of the diamine component to the total molar number of the tetracarboxylic dianhydride component is preferably 0.8 to 1.2. Similar to a general polycondensation reaction, the closer this molar ratio is to 1.0, the greater the molecular weight of the polymer (A) or polymer (B) formed.
具有醯胺酸酯結構之聚合物可例如藉由下述等之習知方法來獲得:(1)使上述方法所獲得之聚醯胺酸進一步與酯化劑反應的方法、(2)使四羧酸二酯化合物與二胺化合物進行反應的方法,或(3)使四羧酸二酯二鹵化物與二胺化合物進行反應的方法。Polymers having an acylamidoester structure can be obtained, for example, by the following known methods: (1) a method of further reacting the polyacylamidoester obtained by the above method with an esterifying agent, (2) a method of reacting a tetracarboxylic acid diester compound with a diamine compound, or (3) a method of reacting a tetracarboxylic acid diester dihalide with a diamine compound.
本發明之液晶配向劑所含的聚合物(A)或聚合物(B)中之醯亞胺化物可例如係藉由將前述所獲得之聚合物予以閉環來獲得。於該醯亞胺化物中,醯胺酸基或其衍生物所具有之官能基的閉環率(亦稱之為醯亞胺化率)不一定須為100%,其醯亞胺化率可根據用途及/或目的任意調整。The imide compound in polymer (A) or polymer (B) contained in the liquid crystal alignment agent of the present invention can be obtained, for example, by ring-closing the polymer obtained above. In the imide compound, the ring-closure ratio (also known as the imidization ratio) of the functional groups possessed by the amino acid group or its derivatives does not necessarily need to be 100%; the imidization ratio can be arbitrarily adjusted according to the application and/or purpose.
對於獲得醯亞胺化物之方法,可例如為將上述反應所獲得之聚合物溶液直接加熱的熱醯亞胺化,或者於聚合物溶液添加觸媒的觸媒醯亞胺化。於溶液中進行熱醯亞胺化時,溫度較佳為100℃至400℃,且更佳為120℃至250℃。於進行熱醯亞胺化時,較佳係一併將醯亞胺化反應所生成之水排除到系統外。The imidization product can be obtained by, for example, directly heating the polymer solution obtained from the above reaction for thermal imidization, or by catalytic imidization in which a catalyst is added to the polymer solution. When thermal imidization is performed in solution, the temperature is preferably 100°C to 400°C, more preferably 120°C to 250°C. During thermal imidization, water generated during the imidization reaction is preferably removed from the system.
前述之觸媒醯亞胺化可例如為於反應所獲得之聚合物溶液中添加鹼性觸媒及酸酐來進行,較佳係於-20℃至250℃,且更佳為於0℃至180℃進行攪拌。鹼性觸媒之添加量較佳為醯胺酸基之0.5莫耳倍至30莫耳倍,且更佳為2莫耳倍至20莫耳倍;酸酐之添加量較佳為醯胺酸基之1莫耳倍至50莫耳倍,且更佳為3莫耳倍至30莫耳倍。鹼性觸媒之具體例可包含但不限於吡啶、三乙胺、三甲胺、三丁胺或三辛胺等。其中,由於吡啶具有使反應進行之適度鹼性,故較理想。酸酐之具體例可包含但不限於乙酸酐、偏苯三甲酸酐或苯均四酸酐等。其中,若使用乙酸酐,反應結束後之純化較容易,故較理想。觸媒醯亞胺化之醯亞胺化率可藉由調整觸媒量、反應溫度及/或反應時間來控制。The aforementioned catalytic imidization can be carried out, for example, by adding an alkaline catalyst and an acid anhydride to the polymer solution obtained from the reaction, preferably with stirring at -20°C to 250°C, and more preferably at 0°C to 180°C. The amount of alkaline catalyst added is preferably 0.5 to 30 mol times, and more preferably 2 to 20 mol times, based on the amount of amide groups; the amount of acid anhydride added is preferably 1 to 50 mol times, and more preferably 3 to 30 mol times, based on the amount of amide groups. Specific examples of alkaline catalysts include, but are not limited to, pyridine, triethylamine, trimethylamine, tributylamine, or trioctylamine. Pyridine is particularly suitable because it has a moderate alkalinity that facilitates the reaction. Specific examples of acid anhydrides include, but are not limited to, acetic anhydride, trimellitic anhydride, or pyromellitic anhydride. Acetic anhydride is preferred because it facilitates purification after the reaction. The imidization rate in the catalytic imidization reaction can be controlled by adjusting the catalyst amount, reaction temperature, and/or reaction time.
當從上述醯亞胺化之反應溶液回收所形成之醯亞胺化物時,將反應溶液投入到溶劑並使其沉澱即可。沉澱使用之溶劑可例如包含但不限於甲醇、乙醇、異丙醇、丙酮、己烷、丁基賽珞蘇(butyl cellosolve)、庚烷、甲乙酮、甲基異丁基酮、甲苯、苯或水等。過濾並回收投入至溶劑所沉澱之聚合物後,其可於常壓或減壓下,常溫或加熱乾燥。或者,將沉澱回收之聚合物再次溶於溶劑,並進行再沉澱回收,此操作重複進行2次至10次,可減少聚合物中之雜質。所使用之溶劑可例如為醇類或酮類烴等。若使用於其中所選出之三種以上的溶劑,精製之效率可進一步提高,故較理想。When the imide formed is recovered from the above-mentioned imidization reaction solution, the reaction solution is added to a solvent and precipitated. The solvent used for precipitation may include, but is not limited to, methanol, ethanol, isopropanol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, toluene, benzene or water. After filtering and recovering the polymer precipitated in the solvent, it can be dried at room temperature or under normal pressure or reduced pressure. Alternatively, the polymer recovered by precipitation can be dissolved in a solvent again and recovered by reprecipitation. This operation can be repeated 2 to 10 times to reduce impurities in the polymer. The solvent used can be, for example, an alcohol or a ketone. If more than three of the selected solvents are used, the refining efficiency can be further improved, which is more ideal.
聚合物之溶液黏度與分子量Solution viscosity and molecular weight of polymers
於配置成濃度為10 wt%至15 wt%之溶液時,本發明之聚合物(A)或聚合物(B)的溶液濃度沒有特別之限制,基於較易操作之觀點,其溶液濃度可例如為10 mPa・s至1000 mPa・s。所述聚合物之溶液黏度(mPa・s)係使用該聚合物之良溶劑(例如:γ-丁內酯或N-甲基-2-吡咯烷酮等)配製成濃度為10 wt%至15 wt%之聚合物溶液,並使用E型旋轉黏度計於25℃所測得之數值。When prepared into a solution with a concentration of 10 wt% to 15 wt%, the concentration of the polymer (A) or polymer (B) of the present invention is not particularly limited. For ease of operation, the solution concentration can be, for example, 10 mPa·s to 1000 mPa·s. The viscosity (mPa·s) of the polymer solution is the value measured at 25°C using an E-type rotational viscometer using a good solvent for the polymer (e.g., γ-butyrolactone or N-methyl-2-pyrrolidone) to prepare a polymer solution with a concentration of 10 wt% to 15 wt%.
本發明之聚合物(A)或聚合物(B)利用凝膠滲透層析(GPC)所測得以聚苯乙烯換算之重量平均分子量(M w)較佳為1,000至500,000,且更佳為2,000至500,000。其次,M w與利用GPC所測得以聚苯乙烯換算之數量平均分子量(M n)的比值所表示之分子量分布(M w/M n)較佳為15以下,且更佳為10以下。當聚合物之分子量為前述之分子量範圍時,其可確保液晶顯示元件之良好配向性及安定性。 The polymer (A) or polymer (B) of the present invention preferably has a weight average molecular weight ( Mw ) in terms of polystyrene, as measured by gel permeation chromatography ( GPC ), of 1,000 to 500,000, and more preferably 2,000 to 500,000. Furthermore, the molecular weight distribution ( Mw / Mn ), represented by the ratio of Mw to the number average molecular weight ( Mn ) in terms of polystyrene, as measured by GPC, is preferably 15 or less, and more preferably 10 or less. When the molecular weight of the polymer is within the aforementioned range, it can ensure good alignment and stability of the liquid crystal display device.
封端劑Capping agent
當合成本發明之聚合物(A)或聚合物(B)時,可使用如前所述之四羧酸二酐組份及二胺組份,且併用適當的封端劑來合成末端密封型的聚合物。末端密封型的聚合物具有可提升利用塗膜所獲得之液晶配向膜的膜硬度,以及提升密封劑及液晶配向膜之密合特性的效果。本發明之聚合物(A)或聚合物(B)之末端可例如包含胺基、羧基、酸酐基或該等之衍生物。胺基、羧基、酸酐基或該等之衍生物可藉由一般之縮合反應來獲得,或者藉由使用後述之封端劑來密封末端所獲得。相同地,前述之衍生物可例如使用下述之封端劑來獲得。When synthesizing the polymer (A) or polymer (B) of the present invention, the tetracarboxylic dianhydride component and the diamine component as described above can be used, and an appropriate end-capping agent can be used to synthesize an end-sealed polymer. The end-sealed polymer has the effect of improving the film hardness of the liquid crystal alignment film obtained by coating, and improving the adhesion properties of the sealant and the liquid crystal alignment film. The end of the polymer (A) or polymer (B) of the present invention may, for example, contain an amino group, a carboxyl group, an acid anhydride group or a derivative thereof. The amino group, carboxyl group, acid anhydride group or a derivative thereof can be obtained by a general condensation reaction, or by sealing the end using the end-capping agent described later. Similarly, the aforementioned derivatives can be obtained, for example, using the following end-capping agent.
舉例而言,封端劑可例如包含但不限於乙酸酐、馬來酸酐、奈地酸酐、鄰苯二甲酸酐、衣康酸酐、環己烷二羧酸酐、3-羥基鄰苯二甲酸酐、偏苯三甲酸酐、3-((3-三甲氧基矽基)丙基)-3,4-二氫呋喃-2,5-二酮、4,5,6,7-四氟異苯并呋喃-1,3-二酮或4-乙炔基鄰苯二甲酸酐等酸酐;二碳酸二第三丁酯或二碳酸二烯丙酯等二碳酸二酯化合物;丙烯醯氯、甲基丙烯醯氯或菸鹼醯氯等氯羰基化合物;苯胺、2-胺基苯酚、3-胺基苯酚、4-胺基水楊酸、5-胺基水楊酸、6-胺基水楊酸、2-胺基苯甲酸、3-胺基苯甲酸、4-胺基苯甲酸、環己胺、正丁胺、正戊胺、正己胺、正庚胺或正辛胺等單元胺化合物;乙基異氰酸酯、苯基異氰酸酯或萘基異氰酸酯等單異氰酸酯化合物等。For example, the end-capping agent may include, but is not limited to, anhydrides such as acetic anhydride, maleic anhydride, nedic anhydride, phthalic anhydride, itaconic anhydride, cyclohexanedicarboxylic anhydride, 3-hydroxyphthalic anhydride, trimellitic anhydride, 3-((3-trimethoxysilyl)propyl)-3,4-dihydrofuran-2,5-dione, 4,5,6,7-tetrafluoroisobenzofuran-1,3-dione or 4-ethynylphthalic anhydride; dibutyl dicarbonate or diallyl dicarbonate; Carbonic acid diester compounds; chlorocarbonyl compounds such as acryloyl chloride, methacryloyl chloride, or nicotinyl chloride; monoamine compounds such as aniline, 2-aminophenol, 3-aminophenol, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, or n-octylamine; monoisocyanate compounds such as ethyl isocyanate, phenyl isocyanate, or naphthyl isocyanate, etc.
所述封端劑可單獨一種使用或混合複數種使用。The blocking agents may be used alone or in combination.
基於二胺組份的總使用量為100莫耳份,封端劑之使用量較佳可為0.01莫耳份至20莫耳份,且更佳為0.01莫耳份至10莫耳份。Based on 100 mol parts of the total diamine component used, the amount of the end-capping agent used is preferably 0.01 mol parts to 20 mol parts, and more preferably 0.01 mol parts to 10 mol parts.
液晶配向劑中之其他成分Other ingredients in liquid crystal alignment agents
本發明之液晶配向劑可包含聚合物(A)、視需要所添加之聚合物(B)。除聚合物(A)與聚合物(B),本發明之液晶配向劑可選擇性地包含其他聚合物。其他聚合物之種類可例如包含但不限於聚酯、聚醯胺、聚脲、聚有機矽氧烷、纖維素衍生物、聚縮醛、聚苯乙烯或其衍生物、聚(苯乙烯-苯基馬來醯亞胺)衍生物,或聚(甲基)丙烯酸酯等。The liquid crystal alignment agent of the present invention may include a polymer (A) and, if necessary, a polymer (B). In addition to polymers (A) and (B), the liquid crystal alignment agent of the present invention may optionally include other polymers. Examples of such other polymers include, but are not limited to, polyesters, polyamides, polyureas, polyorganosiloxanes, cellulose derivatives, polyacetals, polystyrene or its derivatives, poly(styrene-phenylmaleimide) derivatives, or poly(meth)acrylates.
溶劑(C)Solvent (C)
基於形成均勻薄膜的觀點,液晶配向劑採取塗佈液之形態,以製作液晶配向膜。本發明之液晶配向劑較佳為含有上述聚合物成分及有機溶劑(後述將其稱之為溶劑(C))之塗佈液。其中,基於所設定之欲形成的塗膜厚度,液晶配向劑中之聚合物濃度可適當改變。基於形成均勻且無缺陷之塗膜的觀點,液晶配向劑中之聚合物濃度較佳為1 wt%以上。基於溶液之保存安定性的觀點,液晶配向劑中之聚合物濃度較佳為10 wt%以下。理想的聚合物濃度可為2 wt%至8 wt%。液晶配向劑中之聚合物(A)的含量可藉由液晶配向劑之塗佈方法及/或所欲液晶配向膜之膜厚來適當改變,其較佳可為2 wt%至10 wt%,且更佳為3 wt%至7 wt%。From the perspective of forming a uniform thin film, the liquid crystal alignment agent is in the form of a coating liquid to produce a liquid crystal alignment film. The liquid crystal alignment agent of the present invention is preferably a coating liquid containing the above-mentioned polymer component and an organic solvent (hereinafter referred to as solvent (C)). Among them, based on the set coating thickness to be formed, the polymer concentration in the liquid crystal alignment agent can be appropriately changed. From the perspective of forming a uniform and defect-free coating, the polymer concentration in the liquid crystal alignment agent is preferably above 1 wt%. From the perspective of the storage stability of the solution, the polymer concentration in the liquid crystal alignment agent is preferably below 10 wt%. The ideal polymer concentration can be 2 wt% to 8 wt%. The content of polymer (A) in the liquid crystal alignment agent can be appropriately changed by the liquid crystal alignment agent coating method and/or the desired liquid crystal alignment film thickness, and is preferably 2 wt % to 10 wt %, and more preferably 3 wt % to 7 wt %.
液晶配向劑所含之有機溶劑沒有特別之限制,其僅須可將前述之聚合物均勻溶解即可。其具體例可例如包含但不限於N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N,N-二甲基乳醯胺、N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、二甲基亞碸、γ-丁內酯、γ-戊內酯、1,3-二甲基-2-咪唑啶酮、甲乙酮、環己酮、環戊酮、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺、N-(正丙基)-2-吡咯烷酮、N-異丙基-2-吡咯烷酮、N-(正丁基)-2-吡咯烷酮、N-(第三丁基)-2-吡咯烷酮、N-(正戊基)-2-吡咯烷酮、N-甲氧基丙基-2-吡咯烷酮、N-乙氧基乙基-2-吡咯烷酮、N-甲氧基丁基-2-吡咯烷酮或N-環己基-2-吡咯烷酮等,而前述之有機溶劑亦稱之為良溶劑。其中,N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、3-甲氧基-N,N-二甲基丙醯胺、3-丁氧基-N,N-二甲基丙醯胺或γ-丁內酯為較佳。基於液晶配向劑中溶劑的總使用量為100 wt%,良溶劑之使用量可為20 wt%至99 wt%,較佳為20 wt%至90 wt%,且更佳為30 wt%至80 wt%。There is no particular limitation on the organic solvent contained in the liquid crystal alignment agent, as long as it can uniformly dissolve the aforementioned polymer. Specific examples include, but are not limited to, N,N-dimethylformamide, N,N-dimethylacetamide, N,N-dimethyllactamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethylsulfoxide, γ-butyrolactone, γ-valerolactone, 1,3-dimethyl-2-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N,N-dimethylpropionamide, N-(n-propyl)-2-pyrrolidone, N-isopropyl-2-pyrrolidone, N-(n-butyl)-2-pyrrolidone, N-(tert-butyl)-2-pyrrolidone, N-(n-pentyl)-2-pyrrolidone, N-methoxypropyl-2-pyrrolidone, N-ethoxyethyl-2-pyrrolidone, N-methoxybutyl-2-pyrrolidone, or N-cyclohexyl-2-pyrrolidone, etc., and the aforementioned organic solvents are also referred to as good solvents. Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, 3-methoxy-N,N-dimethylpropionamide, 3-butoxy-N,N-dimethylpropionamide, or γ-butyrolactone are preferred. Based on 100 wt% of the total amount of solvent used in the liquid crystal alignment agent, the amount of good solvent used may be 20 wt% to 99 wt%, preferably 20 wt% to 90 wt%, and more preferably 30 wt% to 80 wt%.
其次,液晶配向劑中之有機溶劑較佳係併用前述之溶劑,以及可提升液晶配向劑塗佈時之塗佈性與塗膜之表面平滑性的溶劑(亦稱之為貧溶劑)的混合溶劑。所併用之不良溶劑之具體可例如但不限於後述之溶劑。基於液晶配向劑中之溶劑的總使用量為100 wt%,貧溶劑之使用量較佳為1 wt%至80 wt%,更佳為10 wt%至80 wt%,且尤佳為20 wt%至70 wt%。貧溶劑之種類及使用量可依據液晶配向劑之塗佈裝置、塗佈條件及/或塗佈環境等適當選擇。Secondly, the organic solvent in the liquid crystal alignment agent is preferably a mixed solvent comprising the aforementioned solvents and a solvent that improves the coating properties and surface smoothness of the coating film during coating (also known as a poor solvent). Specific examples of the poor solvent used include, but are not limited to, the solvents described below. Based on a total solvent usage of 100 wt% in the liquid crystal alignment agent, the usage of the poor solvent is preferably 1 wt% to 80 wt%, more preferably 10 wt% to 80 wt%, and even more preferably 20 wt% to 70 wt%. The type and amount of solvent used can be appropriately selected based on the liquid crystal alignment agent coating equipment, coating conditions, and/or coating environment.
舉例而言,貧溶劑可例如為:二異丙醚、二異丁醚、二異丁基甲醇(2,6-二甲基-4-庚醇)、乙二醇二甲醚、乙二醇二乙醚、乙二醇二丁醚、1,2-丁氧基乙烷、二乙二醇二甲醚、二乙二醇二乙醚、4-羥基-4-甲基-2-戊酮、二乙二醇甲基乙醚、二乙二醇二丁醚、3-乙氧基丁基乙酸酯、1-甲基戊基乙酸酯、2-乙基丁基乙酸酯、2-乙基己基乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、碳酸伸丙酯、碳酸伸乙酯、乙二醇單丁醚(丁基賽珞蘇)、乙二醇單異戊醚、乙二醇單己醚、丙二醇單丁醚、1-(2-丁氧基乙氧基)-2-丙醇、2-(2-丁氧基乙氧基)-1-丙醇、丙二醇單甲醚乙酸酯、丙二醇二乙酸酯、二丙二醇單甲醚、二丙二醇單乙醚、二丙二醇二甲醚、乙二醇單丁醚乙酸酯、二乙二醇單乙醚乙酸酯、二乙二醇單丁醚乙酸酯、2-(2-乙氧基乙氧基)乙基乙酸酯、二乙二醇乙酸酯、丙二醇二乙酸酯、乙酸正丁酯、乙酸丙二醇單乙醚、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、3-甲氧基丙酸乙酯、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乳酸正丁酯、乳酸異戊酯、二乙二醇單乙醚,或二異丁基酮(2,6-二甲基-4-庚酮)等。For example, the anisotropic solvent may be diisopropyl ether, diisobutyl ether, diisobutyl carbinol (2,6-dimethyl-4-heptanol), ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, 1,2-butoxyethane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, 4-hydroxy-4-methyl-2-pentanone, diethylene glycol methyl ethyl ether, diethylene glycol dibutyl ether, 3-ethoxybutyl acetate, 1-methylpentyl acetate, 2-ethylbutyl acetate, 2-ethylhexyl acetate, ethylene glycol monoacetate, ethylene glycol diacetate, propylene carbonate, ethyl carbonate, ethylene glycol monobutyl ether (butyl cellulose), ethylene glycol monoisopentyl ether, ethylene glycol monohexyl ether, propylene glycol monobutyl ether, 1-(2-butoxyethoxy) )-2-propanol, 2-(2-butoxyethoxy)-1-propanol, propylene glycol monomethyl ether acetate, propylene glycol diacetate, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol dimethyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, 2-(2-ethoxyethoxy)ethyl acetate, diethylene glycol acetate, propylene glycol diacetate, n-butyl acetate, propylene glycol monoethyl ether acetate, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, propyl 3-methoxypropionate, butyl 3-methoxypropionate, n-butyl lactate, isoamyl lactate, diethylene glycol monoethyl ether, or diisobutyl ketone (2,6-dimethyl-4-heptanone), etc.
其中,二異丁基甲醇、丙二醇單丁醚、丙二醇二乙酸酯、二乙二醇二乙醚、二丙二醇單甲醚、二丙二醇二甲醚、4-羥基-4-甲基-2-戊酮、乙二醇單丁醚、乙二醇單丁醚乙酸酯,或二異丁基酮為較佳。Among them, diisobutyl carbinol, propylene glycol monobutyl ether, propylene glycol diacetate, diethylene glycol diethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol dimethyl ether, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, or diisobutyl ketone is preferred.
良溶劑與貧溶劑之溶劑組合較佳可例如但不限於N-甲基-2-吡咯烷酮與乙二醇單丁醚;N-甲基-2-吡咯烷酮、γ-丁內酯與乙二醇單丁醚;N-甲基-2-吡咯烷酮、γ-丁內酯與丙二醇單丁醚;N-乙基-2-吡咯烷酮與丙二醇單丁醚;N-乙基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮;N-乙基-2-吡咯烷酮與丙二醇二乙酸酯;N,N-二甲基乳醯胺與二異丁基酮;N-甲基-2-吡咯烷酮與3-乙氧基丙酸乙酯;N-乙基-2-吡咯烷酮與3-乙氧基丙酸乙酯;N-甲基-2-吡咯烷酮與乙二醇單丁醚乙酸酯;N-乙基-2-吡咯烷酮與二丙二醇二甲醚;N,N-二甲基乳醯胺與乙二醇單丁醚;N,N-二甲基乳醯胺與丙二醇二乙酸酯;N-乙基-2-吡咯烷酮與二乙二醇二乙醚;N,N-二甲基乳醯胺與二乙二醇二乙醚;N-甲基-2-吡咯烷酮、γ-丁內酯、4-羥基-4-甲基-2-戊酮與二乙二醇二乙醚;N-乙基-2-吡咯烷酮、N-甲基-2-吡咯烷酮與4-羥基-4-甲基-2-戊酮;N-乙基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與丙二醇單丁醚;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與二異丁基酮;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與二丙二醇單甲醚;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與丙二醇單丁醚;N-甲基-2-吡咯烷酮、4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯;γ-丁內酯、4-羥基-4-甲基-2-戊酮與二異丁基酮;γ-丁內酯、4-羥基-4-甲基-2-戊酮與丙二醇二乙酸酯;N-甲基-2-吡咯烷酮、γ-丁內酯、丙二醇單丁醚與二異丁基酮;N-甲基-2-吡咯烷酮、γ-丁內酯與丙二醇單丁醚與二異丙醚;N-甲基-2-吡咯烷酮、γ-丁內酯、丙二醇單丁醚與二異丁基甲醇;N-甲基-2-吡咯烷酮、γ-丁內酯與二丙二醇二甲醚;N-甲基-2-吡咯烷酮、丙二醇單丁醚與二丙二醇二甲醚;N-乙基-2-吡咯烷酮、丙二醇單丁醚與二丙二醇單甲醚;N-乙基-2-吡咯烷酮、丙二醇單丁醚與丙二醇二乙酸酯;N-乙基-2-吡咯烷酮、丙二醇單丁醚與二異丁基酮;N-乙基-2-吡咯烷酮、γ-丁內酯與二異丁基酮;或者N-乙基-2-吡咯烷酮、N,N-二甲基乳醯胺與二異丁基酮等。The solvent combination of good solvent and poor solvent is preferably, for example, but not limited to, N-methyl-2-pyrrolidone and ethylene glycol monobutyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone and ethylene glycol monobutyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone and propylene glycol monobutyl ether; N-ethyl-2-pyrrolidone and propylene glycol monobutyl ether; N-ethyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone; N-ethyl-2-pyrrolidone and propylene glycol diacetate; N,N-dimethyllactamide and diisobutyl ketone; N-methyl-2-pyrrolidone and ethyl 3-ethoxypropionate; N-ethyl-2-pyrrolidone and ethyl 3-ethoxypropionate; N-methyl-2-pyrrolidone and ethyl Glycol monobutyl ether acetate; N-ethyl-2-pyrrolidone and dipropylene glycol dimethyl ether; N,N-dimethyl lactamide and ethylene glycol monobutyl ether; N,N-dimethyl lactamide and propylene glycol diacetate; N-ethyl-2-pyrrolidone and diethylene glycol diethyl ether; N,N-dimethyl lactamide and diethylene glycol diethyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone and diethylene glycol diethyl ether; N-ethyl-2-pyrrolidone, N-methyl-2-pyrrolidone and 4-hydroxy-4-methyl-2-pentanone; N-ethyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol monobutyl ether; N-methyl-2-pyrrolidone, 4-Hydroxy-4-methyl-2-pentanone and diisobutyl ketone; N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and dipropylene glycol monomethyl ether; N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol monobutyl ether; N-methyl-2-pyrrolidone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate; γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone and diisobutyl ketone; γ-butyrolactone, 4-hydroxy-4-methyl-2-pentanone and propylene glycol diacetate; N-methyl-2-pyrrolidone, γ-butyrolactone, propylene glycol monobutyl ether and diisobutyl ketone; N-methyl-2-pyrrolidone, γ-butyrolactone and propylene glycol diacetate. Glycol monobutyl ether and diisopropyl ether; N-methyl-2-pyrrolidone, γ-butyrolactone, propylene glycol monobutyl ether, and diisobutyl carbinol; N-methyl-2-pyrrolidone, γ-butyrolactone, and dipropylene glycol dimethyl ether; N-methyl-2-pyrrolidone, propylene glycol monobutyl ether, and dipropylene glycol dimethyl ether; N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether, and dipropylene glycol monomethyl ether; N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether, and propylene glycol diacetate; N-ethyl-2-pyrrolidone, propylene glycol monobutyl ether, and diisobutyl ketone; N-ethyl-2-pyrrolidone, γ-butyrolactone, and diisobutyl ketone; or N-ethyl-2-pyrrolidone, N,N-dimethyllactamide, and diisobutyl ketone, etc.
前述之溶劑(C)可單獨一種使用或混合複數種使用。The aforementioned solvent (C) may be used alone or in combination of two or more.
基於聚合物(A)與聚合物(B)合計的使用量為100重量份,溶劑(C)的使用量為800重量份至4000重量份,較佳為900重量份至3500重量份,且更佳為1000至3000重量份。Based on 100 parts by weight of the total amount of polymer (A) and polymer (B), the amount of solvent (C) used is 800 to 4000 parts by weight, preferably 900 to 3500 parts by weight, and more preferably 1000 to 3000 parts by weight.
添加劑additives
本發明之液晶配向劑亦可選擇性添加聚合物成分及有機溶劑以外的成分(下述稱之為添加劑成分)。此些添加劑成分可例如包含但不限於:用以提高液晶配向膜與基板之密合性或液晶配向膜與密封劑之密合性的密合助劑、用以提高液晶配向膜之強度的化合物(下述稱之為交聯性化合物)、用以促進醯亞胺化的化合物、用以調整液晶配向膜之介電常數或電阻之介電體或導電物質等。The liquid crystal alignment agent of the present invention may also optionally contain ingredients other than the polymer component and the organic solvent (hereinafter referred to as additives). These additives may include, but are not limited to: adhesion promoters for improving the adhesion between the liquid crystal alignment film and the substrate or between the liquid crystal alignment film and the sealant, compounds for increasing the strength of the liquid crystal alignment film (hereinafter referred to as crosslinking compounds), compounds for promoting imidization, and dielectrics or conductive substances for adjusting the dielectric constant or resistance of the liquid crystal alignment film.
密合助劑Sealing agent
前述之密合助劑可例如為3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、3-胺基丙基二乙氧基甲基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽基丙基三伸乙基三胺、N-三甲氧基矽基丙基三伸乙基三胺、乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二甲氧基矽烷、3-環氧丙氧基丙基三甲氧基矽烷、3-環氧丙氧基丙基甲基二乙氧基矽烷、3-環氧丙氧基丙基三乙氧基矽烷、3-甲基丙烯醯氧基丙基甲基二甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基甲基二乙氧基矽烷、3-甲基丙烯醯氧基丙基三乙氧基矽烷、3-丙烯醯氧基丙基三甲氧基矽烷、參(3-三甲氧基矽基丙基)異氰尿酸酯,或3-異氰酸酯丙基三乙氧基矽烷等矽烷偶合劑。使用密合助劑時,基於對於AC殘影展現良好耐性之觀點,相對於液晶配向劑中聚合物的總使用量為100重量份,密合助劑之使用量較佳為0.1重量份至30重量份,且更佳為0.1重量份至20重量份。The aforementioned adhesion promoter may be, for example, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-aminopropyldiethoxymethylsilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, N-ethoxycarbonyl-3-aminopropyltrimethoxysilane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilylpropyltriethylenetriamine, N-trimethoxysilylpropyltriethylenetriamine, vinyltrimethoxysilane, Silane, vinyl triethoxysilane, 2-(3,4-epoxycyclohexyl)ethyl trimethoxysilane, 3-glycidoxypropylmethyldimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, 3-glycidoxypropyltriethoxysilane, 3-methacryloyloxypropylmethyldimethoxysilane Silane coupling agents such as methoxysilane, 3-methacryloxypropyltrimethoxysilane, 3-methacryloxypropylmethyldiethoxysilane, 3-methacryloxypropyltriethoxysilane, 3-acryloxypropyltrimethoxysilane, tris(3-trimethoxysilylpropyl)isocyanurate, or 3-isocyanatepropyltriethoxysilane are also used. When a bonding agent is used, the amount of the bonding agent used is preferably 0.1 to 30 parts by weight, and more preferably 0.1 to 20 parts by weight, relative to 100 parts by weight of the total amount of the polymer in the liquid crystal alignment agent, in order to exhibit good resistance to AC residual image.
交聯性化合物Cross-linked compounds
對於前述之交聯性化合物,基於對AC殘影展現良好耐性且有效改善膜強度的觀點,其可為具有環氧乙烷基、環氧丙烷基、選自於由如下式(E1)所示之基團及下式(E2)所示之基團所組成之群組中的至少一種基團之化合物,或選自如下式(E3)所示之化合物中的化合物。 (E1) (E2) (E3) The crosslinking compound described above may be a compound having an ethylene oxide group, an propylene oxide group, at least one group selected from the group consisting of a group represented by the following formula (E1) and a group represented by the following formula (E2), or a compound selected from the compound represented by the following formula (E3), from the viewpoint of exhibiting good resistance to AC afterimages and effectively improving film strength. (E1) (E2) (E3)
於式(E1)中,G 1及G 2各自獨立地表示氫原子、碳數為1至3之烷基或-CH 2-OH。於式(E2)中,G 3表示碳數為1至6之烷基、碳數為2至6之烯基或碳數為2至6之炔基。G 4表示氫原子、碳數為1至4之烷基、碳數為2至6之烯基或碳數為2至6之炔基。於式(E3)中,G 5表示含有芳香環之(g1+g2)價有機基團。G 6表示氫原子或碳數為1至5之烷基。g1表示1至6之整數,g2表示0至4之整數。 In formula (E1), G1 and G2 each independently represent a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, or -CH2 - OH. In formula (E2), G3 represents an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, or an alkynyl group having 2 to 6 carbon atoms. G4 represents a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, or an alkynyl group having 2 to 6 carbon atoms. In formula (E3), G5 represents a (g1+g2)-valent organic group containing an aromatic ring. G6 represents a hydrogen atom or an alkyl group having 1 to 5 carbon atoms. g1 represents an integer from 1 to 6, and g2 represents an integer from 0 to 4.
於式(E3)中,G 5所代表之具有芳香環的(g1+g2)價有機基團可列舉碳數為6至30之(g1+g2)價芳香族烴基、碳數為6至30之芳香族烴基直接或介隔連結基所鍵結形成之(g1+g2)價有機基團,或具有芳香族雜環之(g1+g2)價基團。所述芳香族烴可例如為苯或萘等。所述芳香族雜環可列舉為上述特定之含氮原子結構之例示芳香族雜環。所述連結基可列舉碳數為1至10之伸烷基或從該伸烷基取走一個氫原子之基團,或者二價或三價之環己烷等。其中,該伸烷基之任意氫原子也可被取代為氟原子或三氟甲基等有機基團。於式(E3)中,G 6所代表之碳數為1至5之烷基可列舉甲基、乙基、丙基、異丙基、正丁基、異丁基、第二丁基、第三丁基或正戊基。 In formula (E3), the (g1+g2)-valent organic group having an aromatic ring represented by G5 can be a (g1+g2)-valent aromatic alkyl group having 6 to 30 carbon atoms, a (g1+g2)-valent organic group formed by directly or via a linking group bonding an aromatic alkyl group having 6 to 30 carbon atoms, or a (g1+g2)-valent group having an aromatic heterocyclic ring. The aromatic alkyl group can be, for example, benzene or naphthalene. The aromatic heterocyclic ring can be exemplified by the aromatic heterocyclic rings of the aforementioned specific nitrogen-containing structures. The linking group can be an alkylene group having 1 to 10 carbon atoms, a group obtained by removing a hydrogen atom from the alkylene group, or a divalent or trivalent cyclohexane. Any hydrogen atom of the alkylene group may be substituted with a fluorine atom or an organic group such as a trifluoromethyl group. In formula (E3), the alkyl group having 1 to 5 carbon atoms represented by G6 can be methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, or n-pentyl.
具環氧乙烷基之化合物Compounds with ethylene oxide groups
具環氧乙烷基之化合物的具體例可列舉N,N,N',N'-四環氧丙基間二甲苯二胺、1,3-雙(N,N-二環氧丙胺基甲基)環己烷、N,N,N',N'-四環氧丙基-4,4'-二胺基二苯基甲烷、N,N,N',N'-四環氧丙基-對苯二胺、如下式(E4)至式(E6)所示等含有氮原子之化合物。 (E4) (E5) (E6) Specific examples of the compound having an oxirane group include N,N,N',N'-tetraoxopropyl-m-xylenediamine, 1,3-bis(N,N-dioxopropylaminomethyl)cyclohexane, N,N,N',N'-tetraoxopropyl-4,4'-diaminodiphenylmethane, N,N,N',N'-tetraoxopropyl-p-phenylenediamine, and nitrogen-containing compounds such as those represented by the following formulas (E4) to (E6). (E4) (E5) (E6)
具有環氧丙烷基之化合物Compounds with propylene oxide groups
具有環氧丙烷基之化合物的具體例可列舉如下式(E7)至式(E16)所示之化合物。 (E7) (E8) (E9) (E10) (E11) (E12) (E13) (E14) (E15) (E16) Specific examples of the compound having an propylene oxide group include compounds represented by the following formulas (E7) to (E16). (E7) (E8) (E9) (E10) (E11) (E12) (E13) (E14) (E15) (E16)
於式(E15)中,R代表 ,其中「*」代表鍵結位置。 In formula (E15), R represents , where "*" represents the key position.
具有如式(E1)所示之基團的化合物Compounds having a group represented by formula (E1)
具有如式(E1)所示之基團的化合物之具體例可列舉如下式(E1-1)至式(E1-12)所示之化合物。 (E1-1) (E1-2) (E1-3) (E1-4) (E1-5) (E1-6) (E1-7) (E1-8) (E1-9) (E1-10) (E1-11) (E1-12) Specific examples of the compound having the group represented by formula (E1) include compounds represented by the following formulas (E1-1) to (E1-12). (E1-1) (E1-2) (E1-3) (E1-4) (E1-5) (E1-6) (E1-7) (E1-8) (E1-9) (E1-10) (E1-11) (E1-12)
具有如式(E2)所示基團之化合物Compounds having a group represented by formula (E2)
具有如式(E2)所示基團之化合物的具體例可列舉如下式(E2-1)至式(E2-4)所示之化合物。 (E2-1) (E2-2) (E2-3) (E2-4) Specific examples of the compound having the group represented by formula (E2) include the compounds represented by the following formulas (E2-1) to (E2-4). (E2-1) (E2-2) (E2-3) (E2-4)
具有如式(E3)所示基團之化合物Compounds having a group represented by formula (E3)
具有如式(E3)所示基團之化合物的具體例可如下式(E3-1)至式(E3-10)所示之化合物。 (E3-1) (E3-2) (E3-3) (E3-4) (E3-5) (E3-6) (E3-7) (E3-8) (E3-9) (E3-10) Specific examples of the compound having the group represented by formula (E3) include compounds represented by the following formulas (E3-1) to (E3-10). (E3-1) (E3-2) (E3-3) (E3-4) (E3-5) (E3-6) (E3-7) (E3-8) (E3-9) (E3-10)
本發明之液晶配向劑中,基於液晶配向劑中聚合物之總使用量為100重量份,交聯性化合物之使用量較佳為0.5重量份至20重量份。其中,基於交聯反應之進行與對於AC殘影展現良好耐性之觀點,交聯性化合物之使用量更佳為1重量份至15重量份。In the liquid crystal alignment agent of the present invention, the amount of the crosslinking compound used is preferably 0.5 to 20 parts by weight based on 100 parts by weight of the total polymer used in the liquid crystal alignment agent. Furthermore, based on the perspectives of crosslinking reaction progress and good resistance to AC afterimages, the amount of the crosslinking compound used is more preferably 1 to 15 parts by weight.
促進醯亞胺化之化合物Compounds that promote imidization
前述用以促進醯亞胺化之化合物較佳為具有鹼性部位(例如:一級胺基、脂肪族雜環(如吡咯啶骨架)、芳香族雜環(如咪唑環或吲哚環),或胍基等)之化合物(惟上述交聯性化合物及密合助劑除外),或者煅燒時會產生所述鹼性部位之化合物。更佳地,促進醯亞胺化之化合物為煅燒時會產生所述鹼性部位之化合物,其具體例可例如為胺基酸所具有之鹼性部位的一部分或全部係被保護之胺基酸。上述胺基酸之具體例可列舉甘胺酸、丙胺酸、半胱胺酸、甲硫胺酸、天冬醯胺、麩醯胺酸、纈胺酸、白胺酸、苯丙胺酸、酪胺酸、色胺酸、脯胺酸、羥基脯胺酸、精胺酸、組胺酸、離胺酸,或鳥胺酸。基於促進醯亞胺化之化合物之目的,更佳的具體例可列舉為N-α-(9-茀基甲氧基羰基)-N-τ-(第三丁氧基羰基)-L-組胺酸。The compound used to promote imidization is preferably a compound (excluding the crosslinking compound and bonding aid) having a basic site (e.g., a primary amine group, an aliphatic heterocycle (e.g., a pyrrolidine skeleton), an aromatic heterocycle (e.g., an imidazole ring or an indole ring), or a guanidine group), or a compound that generates such a basic site upon calcination. More preferably, the compound promoting imidization is a compound that generates such a basic site upon calcination, and a specific example thereof is an amino acid in which the basic site is partially or entirely protected. Specific examples of the aforementioned amino acids include glycine, alanine, cysteine, methionine, asparagine, glutamine, valine, leucine, phenylalanine, tyrosine, tryptophan, proline, hydroxyproline, arginine, histidine, lysine, or guanine. For the purpose of promoting the amidation of a compound, a more preferred example is N-α-(9-fluorenylmethoxycarbonyl)-N-τ-(tert-butoxycarbonyl)-L-histidine.
液晶配向膜與液晶顯示元件的製作方法Liquid crystal alignment film and method for manufacturing liquid crystal display element
本發明之液晶配向膜係由前述之液晶配向劑所獲得。本發明之液晶配向膜可作為水平配向型或垂直配向型(VA型)之液晶配向膜,且其係適合於IPS方式或FFS方式等水平配向型之液晶顯示元件的液晶配向膜。本發明之液晶顯示元件具備所述之液晶配向膜。本發明之液晶顯示元件可例如藉由下述之步驟(1)至步驟(4)或步驟(1)至步驟(2)與步驟(4)的方法來製作。The liquid crystal alignment film of the present invention is obtained from the aforementioned liquid crystal alignment agent. The liquid crystal alignment film of the present invention can be used as a horizontal alignment type or vertical alignment type (VA type) liquid crystal alignment film, and is suitable for a liquid crystal alignment film of a horizontal alignment type liquid crystal display element such as an IPS mode or an FFS mode. The liquid crystal display element of the present invention has the aforementioned liquid crystal alignment film. The liquid crystal display element of the present invention can be produced, for example, by the following method of steps (1) to (4) or steps (1) to (2) and step (4).
步驟(1):將液晶配向劑塗佈於基板上Step (1): Apply liquid crystal alignment agent on the substrate
利用如輥塗法、旋塗法、印刷法或噴墨法等適當的塗佈方法,在設有經圖案化之透明導電膜的基板之一面上塗佈本發明之液晶配向劑。其中,基板沒有特別之限制,其僅須為高透明性之基板即可,也可將玻璃基板或氮化矽基板與壓克力基板或聚碳酸酯基板等塑膠基板併用。其次,於反射型之液晶顯示元件中,若僅是單側之基板,也能使用矽晶圓等不透明物,且所使用之電極亦可為鋁等可反射光之材料。再者,製作IPS型或FFS型之液晶元件時,梳齒型係使用已設置經圖案化之透明導電膜或金屬膜所構成之電極基板及未設置電極之對向基板。The liquid crystal alignment agent of the present invention is applied to one side of a substrate having a patterned transparent conductive film using an appropriate coating method such as roll coating, spin coating, printing, or inkjet. The substrate is not particularly limited; it only needs to be highly transparent. Glass or silicon nitride substrates can also be used in conjunction with plastic substrates such as acrylic or polycarbonate substrates. Furthermore, in reflective liquid crystal display devices, if only a single-sided substrate is used, opaque materials such as silicon wafers can be used, and the electrodes used can also be made of light-reflective materials such as aluminum. Furthermore, when manufacturing IPS or FFS liquid crystal elements, the comb-tooth type uses an electrode substrate composed of a patterned transparent conductive film or metal film and an opposite substrate without an electrode.
將液晶配向劑塗佈於基板並成膜之方法可列舉網版印刷、平版印刷、柔版印刷、噴墨法或噴塗法等。其中,成膜之方法較佳係利用噴墨法之塗佈。The liquid crystal alignment agent can be applied to the substrate to form a film by screen printing, offset printing, flexographic printing, inkjet printing, or spray coating. Among them, the preferred method for forming the film is inkjet coating.
步驟(2):煅燒所塗佈之液晶配向劑Step (2): calcining the coated liquid crystal alignment agent
步驟(2)係煅燒已塗佈於基板上之液晶配向劑,以形成膜的步驟。將液晶配向劑塗佈於基板上後,可利用熱板、熱循環型烘箱或IR(紅外線)型烘箱等加熱手段使溶劑蒸發,或進行聚醯胺酸或聚醯胺酸酯之熱醯亞胺化。已塗佈本發明之液晶配向劑後所進行之乾燥與煅燒步驟可選擇任意之溫度及時間,且可進行多次乾燥或煅燒步驟。乾燥溫度可例如為40℃至180℃。基於縮短處理之觀點,可於40℃至150℃下進行。乾燥時間沒有特別限定,其可例如為1分鐘至10分鐘或1分鐘至5分鐘。進行聚醯胺酸或聚醯胺酸酯之熱醯亞胺化時,在前述之乾燥步驟後,可進一步於例如150℃至300℃或150℃至250℃之溫度下進行煅燒步驟。煅燒時間沒有特別之限定,其可列舉5分鐘至40分鐘或5分鐘至30分鐘。煅燒後之膜狀物若太薄則液晶顯示元件之可靠性會降低,故膜狀物厚度較佳為5 nm至300 nm,且更佳為10 nm至200 nm。Step (2) is a step of calcining the liquid crystal alignment agent coated on the substrate to form a film. After the liquid crystal alignment agent is coated on the substrate, the solvent can be evaporated by heating means such as a hot plate, a heat circulation oven or an IR (infrared) oven, or thermal imidization of polyamine or polyamine ester can be performed. The drying and calcining steps performed after the liquid crystal alignment agent of the present invention has been coated can be selected at any temperature and time, and multiple drying or calcining steps can be performed. The drying temperature can be, for example, 40°C to 180°C. Based on the viewpoint of shortening the process, it can be carried out at 40°C to 150°C. The drying time is not particularly limited and may be, for example, 1 to 10 minutes or 1 to 5 minutes. When thermal imidization of polyamic acid or polyamic ester is performed, after the aforementioned drying step, a calcination step may be further performed at a temperature of, for example, 150°C to 300°C or 150°C to 250°C. The calcination time is not particularly limited and may be, for example, 5 to 40 minutes or 5 to 30 minutes. If the calcined film is too thin, the reliability of the liquid crystal display device will be reduced. Therefore, the film thickness is preferably 5 nm to 300 nm, and more preferably 10 nm to 200 nm.
步驟(3):對步驟(2)所獲得之膜進行配向處理Step (3): Perform an alignment treatment on the film obtained in step (2)
步驟(3)係視情形對步驟(2)所獲得之膜進行配向處理。換言之,於IPS方式或FFS方式等水平配向型之液晶顯示元件中,對該塗膜實施配向處理,以賦予配向能力。另一方面,於VA方式或PSA模式等垂直配向型之液晶顯示元件中,可將已形成之塗膜直接作為液晶配向膜使用,但也可對該塗膜進行配向處理,以賦予配向能力。液晶配向膜之配向處理可列舉摩擦處理法或光配向處理法,其較佳為光配向處理法。光配向處理法可列舉於上述膜狀物之表面照射已沿一定方向偏向之放射線,並視情形,較佳為以150℃至250℃之溫度加熱,以賦予液晶配向性(亦稱之為液晶配向能力)的方法。放射線可使用波長為100 nm至800 nm之紫外線或可見光線。其中,放射線較佳為波長為100 nm至400 nm之紫外線,且更佳為200 nm至400 nm之紫外線。Step (3) is to perform an alignment treatment on the film obtained in step (2) as appropriate. In other words, in a horizontal alignment type liquid crystal display element such as the IPS mode or the FFS mode, the coating film is subjected to an alignment treatment to impart alignment capability. On the other hand, in a vertical alignment type liquid crystal display element such as the VA mode or the PSA mode, the formed coating film can be used directly as a liquid crystal alignment film, but the coating film can also be subjected to an alignment treatment to impart alignment capability. The alignment treatment of the liquid crystal alignment film can be exemplified by a friction treatment method or a photo-alignment treatment method, with the photo-alignment treatment method being preferred. Photo-alignment treatment methods include irradiating the surface of the aforementioned film with radiation that has been deflected in a specific direction, and optionally heating the film at a temperature of 150°C to 250°C to impart alignment properties (also known as liquid crystal alignment capability) to the liquid crystal. The radiation can be ultraviolet light or visible light with a wavelength of 100 nm to 800 nm. Ultraviolet light with a wavelength of 100 nm to 400 nm is preferred, and ultraviolet light with a wavelength of 200 nm to 400 nm is more preferred.
前述放射線之照射量可為1 mJ/cm 2至10,000 mJ/cm 2,較佳為100 mJ/cm 2至5,000 mJ/cm 2,更佳為100 mJ/cm 2至1500 mJ/cm 2,且尤佳為100 mJ/cm 2至1000 mJ/cm 2。使用一般液晶配向劑時,配向處理之光照射量為100 mJ/cm 2至5000 mJ/cm 2,但本發明之液晶配向劑,即使配向處理之光照射量減少,其仍可獲得膜面內之液晶配向性的變異(不均勻性)有效被抑制之液晶配向膜。於照射放射線時,為了改善液晶配向性,前述膜狀物之基板可於照射同時,以50℃至250℃進行加熱。依此方式所製作之液晶配向膜可使液晶分子按一定的方向穩定配向。其次,前述方法中已照射經偏光之放射線的液晶配向膜可使用溶劑進行接觸處理,或者將已照射放射線之液晶配向膜進行加熱處理。 The radiation dose can be 1 mJ/ cm² to 10,000 mJ/ cm² , preferably 100 mJ/ cm² to 5,000 mJ/ cm² , more preferably 100 mJ/ cm² to 1500 mJ/ cm² , and even more preferably 100 mJ/ cm² to 1000 mJ/ cm² . When conventional liquid crystal alignment agents are used, the light dose for alignment treatment is 100 mJ/ cm² to 5000 mJ/ cm² . However, the liquid crystal alignment agent of the present invention can still produce a liquid crystal alignment film in which variations (non-uniformity) in the liquid crystal alignment property within the film surface are effectively suppressed, even when the light dose for alignment treatment is reduced. During the radiation exposure, the film substrate may be heated to a temperature of 50°C to 250°C to improve the liquid crystal alignment. The liquid crystal alignment film produced in this manner can stably align the liquid crystal molecules in a specific direction. Furthermore, the liquid crystal alignment film irradiated with polarized radiation in the aforementioned method may be contact-treated with a solvent or heated.
前述接觸處理所使用之溶劑沒有特別之限制,其僅須可溶解經放射線照射後,從膜狀物所生成之分解物即可。具體例可列舉水、甲醇、乙醇、2-丙醇、丙酮、甲乙酮、1-甲氧基-2-丙醇、1-甲氧基-2-丙醇乙酸酯、丁基賽珞蘇、乳酸乙酯、乳酸甲酯、二丙酮醇、3-甲氧基丙酸甲酯、3-乙氧基丙酸乙酯、乙酸丙酯、乙酸丁酯,或乙酸環己酯等。其中,基於泛用性與安全性之觀點,較佳為水、2-丙醇、1-甲氧基-2-丙醇或乳酸乙酯,且更佳為水、1-甲氧基-2-丙醇或乳酸乙酯。溶劑可單獨一種使用或混合複數種使用。There are no particular restrictions on the solvent used in the aforementioned contact treatment; it only needs to be able to dissolve the decomposition products generated from the film after irradiation. Specific examples include water, methanol, ethanol, 2-propanol, acetone, methyl ethyl ketone, 1-methoxy-2-propanol, 1-methoxy-2-propanol acetate, butyl celecoxib, ethyl lactate, methyl lactate, diacetone alcohol, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, propyl acetate, butyl acetate, or cyclohexyl acetate. Among these, water, 2-propanol, 1-methoxy-2-propanol, or ethyl lactate are preferred from the perspectives of versatility and safety, and water, 1-methoxy-2-propanol, or ethyl lactate are more preferred. Solvents may be used alone or in combination.
對前述已照射放射線之塗膜進行加熱處理的溫度較佳為50℃至300℃,且更佳為120℃至250℃。加熱處理之時間較佳為1分鐘至30分鐘。The temperature for heat treatment of the radiation-irradiated coating is preferably 50° C. to 300° C., more preferably 120° C. to 250° C. The heat treatment time is preferably 1 minute to 30 minutes.
步驟(4):製作液晶胞Step (4): Making liquid crystal cells
準備兩片前述所形成之液晶配向膜基板,並於面向配置之兩片基板間配置液晶。舉例而言,可列舉下述之兩種方法。第一種方法,首先以各液晶配向膜面對的方式,隔著間隙(晶胞間隙)將兩片基板面向配置。然後,將兩片基板之周邊部以密封劑貼合,再將液晶組成物注入填充至由基板表面及密封劑區隔出的晶胞間隙內,並於其接觸膜面後,密封注入孔。Prepare two substrates with the aforementioned liquid crystal alignment films and arrange the liquid crystal between the two facing substrates. For example, the following two methods can be used. The first method involves placing the two substrates face-to-face, with the liquid crystal alignment films facing each other, separated by a gap (cell gap). Next, the two substrates are bonded together with a sealant around their perimeters. The liquid crystal composition is then injected into the cell gap defined by the substrate surfaces and the sealant. Once the liquid crystal composition contacts the film surface, the injection hole is sealed.
第二種方法,係稱為ODF(液晶滴入式封填;One Drop Fill)之方法。在已形成液晶配向膜之兩片基板中的其中一者之預定位置塗佈如紫外光硬化性之密封劑,再於液晶配向膜面上之多個預定位置滴加液晶組成物。然後,以液晶配向膜相面對的方式貼合另一基板,而將液晶組成物推壓在基板之整面,使其接觸膜面。接著,對基板整面照射紫外光,以使密封劑硬化。依進行前述之任一方法時,較佳係進一步將所使用之液晶組成物加熱至成為等向相的溫度後,緩慢放冷到室溫,以去除液晶填充時之流動配向。其次,對塗膜實施摩擦處理時,兩片基板係以各塗膜之摩擦方向互相成預定角度來面向配置,例如成直交或反向平行之方式。密封劑可例如為含有硬化劑及作為間隔件之氧化鋁球的環氧樹脂等。液晶組成物可列舉向列型液晶及層列型液晶,且較佳為向列型液晶。The second method is called ODF (One Drop Fill) method. A sealant such as a UV-curable sealant is applied to a predetermined position on one of the two substrates on which a liquid crystal alignment film has been formed, and then a liquid crystal composition is added to a plurality of predetermined positions on the surface of the liquid crystal alignment film. Then, the other substrate is attached with the liquid crystal alignment films facing each other, and the liquid crystal composition is pushed onto the entire surface of the substrate so that it contacts the film surface. Then, the entire surface of the substrate is irradiated with ultraviolet light to cure the sealant. When performing any of the aforementioned methods, it is preferred to further heat the liquid crystal composition used to a temperature at which it becomes an isotropic phase, and then slowly cool it to room temperature to remove the flow alignment during liquid crystal filling. Next, when rubbing the coating, the two substrates are positioned so that the rubbing directions of the coatings are at a predetermined angle to each other, such as perpendicular or antiparallel. The sealant may be, for example, an epoxy resin containing a hardener and aluminum oxide balls as spacers. The liquid crystal composition may be nematic or lamellar, with nematic liquid crystal being preferred.
視需要可於液晶胞之外側表面貼合偏光板,以獲得液晶顯示元件。液晶胞之外表面所貼合之偏光板可列舉延伸配向聚乙烯醇並同時吸收碘,且稱為「H膜」的偏光薄膜。其可為以乙酸纖維素保護膜所夾持而成之偏光板,或者H膜本身所構成之偏光板。Optionally, a polarizing plate can be attached to the outer surface of the liquid crystal cell to produce a liquid crystal display. The polarizing plate attached to the outer surface of the liquid crystal cell can be made of a polarizing film called "H-film" that is made of elongated polyvinyl alcohol and absorbs iodine. This can be a polarizing plate sandwiched between cellulose acetate protective films or composed solely of H-film.
以下利用實施例以說明本發明之應用,然其並非用以限定本發明,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾。The following embodiments are used to illustrate the application of the present invention, but they are not used to limit the present invention. Anyone skilled in the art can make various changes and modifications without departing from the spirit and scope of the present invention.
製備聚合物(A)Preparation of polymer (A)
合成例A-1-1Synthesis Example A-1-1
在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入1.215克(0.0035莫耳)的如式(A21-1)所示之化合物(a2-1-1)、6.57克(0.0225莫耳)的如式(A22-2)所示之二胺化合物(a2-2-3)、3.66克(0.015莫耳)的如式(A23-2)所示之二胺化合物(a2-3-2)與1.784克(0.009莫耳)的4,4'-二胺基二苯基甲烷(a2-4-1)及80克的N-甲基-2-吡咯烷酮(以下簡稱NMP),並於室溫下攪拌至溶解。接著,加入11.1克(0.05莫耳)的如式(A11-1)所示之二胺化合物(a1-1-1)及20克的NMP,並於室溫下反應2小時。反應結束後,將反應溶液倒入1500毫升的水中,以析出聚合物,過濾所得之聚合物,並以甲醇重複進行清洗及過濾之步驟三次。之後,將產物置入真空烘箱中,並以溫度60℃進行乾燥,即可製得合成例A-1-1之聚合物(A-1-1),其配方如第1表所示。A 500 ml four-necked Erlenmeyer flask was equipped with a nitrogen inlet, a stirrer, a condenser, and a thermometer, and nitrogen was introduced. Then, 1.215 g (0.0035 mol) of the compound (a2-1-1) represented by formula (A21-1), 6.57 g (0.0225 mol) of the diamine compound (a2-2-3) represented by formula (A22-2), 3.66 g (0.015 mol) of the diamine compound (a2-3-2) represented by formula (A23-2), 1.784 g (0.009 mol) of 4,4'-diaminodiphenylmethane (a2-4-1), and 80 g of N-methyl-2-pyrrolidone (hereinafter referred to as NMP) were added and stirred at room temperature until dissolved. Next, 11.1 g (0.05 mol) of the diamine compound (a1-1-1) represented by formula (A11-1) and 20 g of NMP were added, and the mixture was reacted at room temperature for 2 hours. After the reaction, the reaction solution was poured into 1500 ml of water to precipitate the polymer. The resulting polymer was filtered and then washed and filtered with methanol three times. The product was then placed in a vacuum oven and dried at 60°C to obtain the polymer (A-1-1) of Synthesis Example A-1-1, the formula of which is shown in Table 1.
合成例A-1-2至合成例A-1-6與合成比較例A'-1-1至比較合成例A'-1-7Synthesis Examples A-1-2 to A-1-6 and Comparative Synthesis Examples A'-1-1 to A'-1-7
合成例A-1-2至合成例A-1-6與合成比較例A'-1-1至比較合成例A'-1-7使用與合成例A-1-1之聚合物(A-1-1)的製作方法相同之製備方法,不同之處在於合成例A-1-2至合成例A-1-6與合成比較例A'-1-1至比較合成例A'-1-7改變聚合物中原料的種類與使用量,其配方如第1表所示,此處不另贅述。Synthesis Examples A-1-2 to A-1-6 and Comparative Synthesis Examples A'-1-1 to Comparative Synthesis Examples A'-1-7 use the same preparation method as the preparation method of the polymer (A-1-1) in Synthesis Example A-1-1. The difference is that Synthesis Examples A-1-2 to A-1-6 and Comparative Synthesis Examples A'-1-1 to Comparative Synthesis Examples A'-1-7 change the types and usage amounts of raw materials in the polymers. The formulas are shown in Table 1 and are not described further here.
合成例A-2-1Synthesis Example A-2-1
在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入1.215克(0.0035莫耳)的如式(A21-1)所示之化合物(a2-1-1)、6.57克(0.0225莫耳)的如式(A22-2)所示之二胺化合物(a2-2-3)、3.66克(0.015莫耳)的如式(A23-2)所示之二胺化合物(a2-3-2)與1.784克(0.009莫耳)的4,4'-二胺基二苯基甲烷(a2-4-1)及80克的NMP,並於室溫下攪拌至溶解。接著,加入11.1克(0.05莫耳)的如式(A11-1)所示之二胺化合物(a1-1-1)及20克的NMP。於室溫下反應6小時後,加入97克的NMP、2.55克的醋酸酐及19.75克的吡啶,升溫至60℃,且持續攪拌2小時,以進行醯亞胺化反應。待反應結束後,將反應溶液倒入1500毫升水中,以使聚合物析出。然後,過濾所得的聚合物,並重複以甲醇清洗及過濾三次,置入真空烘箱中,以溫度60℃進行乾燥後,即可製得合成例A-2-1之聚合物(A-2-1),其配方如第1表所示。A 500 ml four-necked Erlenmeyer flask was equipped with a nitrogen inlet, a stirrer, a condenser, and a thermometer, and nitrogen was introduced. Then, 1.215 g (0.0035 mol) of the compound (a2-1-1) represented by formula (A21-1), 6.57 g (0.0225 mol) of the diamine compound (a2-2-3) represented by formula (A22-2), 3.66 g (0.015 mol) of the diamine compound (a2-3-2) represented by formula (A23-2), 1.784 g (0.009 mol) of 4,4'-diaminodiphenylmethane (a2-4-1), and 80 g of NMP were added and stirred at room temperature until dissolved. Next, add 11.1 g (0.05 mol) of the diamine compound (a1-1-1) represented by formula (A11-1) and 20 g of NMP. After reacting at room temperature for 6 hours, add 97 g of NMP, 2.55 g of acetic anhydride and 19.75 g of pyridine, raise the temperature to 60°C, and continue stirring for 2 hours to carry out the imidization reaction. After the reaction is completed, pour the reaction solution into 1500 ml of water to precipitate the polymer. Then, filter the obtained polymer, repeat washing and filtering with methanol three times, place it in a vacuum oven, and dry it at a temperature of 60°C to obtain the polymer (A-2-1) of Synthesis Example A-2-1, whose formula is shown in Table 1.
合成例A-2-2Synthesis Example A-2-2
合成例A-2-2使用與合成例A-2-1之聚合物(A-2-1)的製作方法相同之製備方法,不同之處在於合成例A-2-2改變聚合物中原料的種類與使用量,其配方如第1表所示,此處不另贅述。Synthesis Example A-2-2 uses the same preparation method as the preparation method of the polymer (A-2-1) in Synthesis Example A-2-1. The difference is that Synthesis Example A-2-2 changes the type and amount of raw materials in the polymer. Its formula is shown in Table 1 and is not further described here.
製備聚合物(B)Preparation of polymer (B)
合成例B-1-1至合成例B-1-7Synthesis Example B-1-1 to Synthesis Example B-1-7
合成例B-1-1至合成例B-1-7係使用與合成例A-1-1之聚合物(A-1-1)的製作方法相同之製備方法,不同之處在於合成例B-1-1至合成例B-1-7改變聚合物物中原料的種類與使用量。其配方分別如第2表所示,此處不另贅述。Synthesis Examples B-1-1 through B-1-7 utilize the same preparation method as the polymer (A-1-1) from Synthesis Example A-1-1. The differences between Examples B-1-1 through B-1-7 are the type and amount of raw materials used in the polymers. Their respective formulations are shown in Table 2 and are not further detailed here.
合成例B-2-1至合成例B-2-2Synthesis Example B-2-1 to Synthesis Example B-2-2
合成例B-2-1至合成例B-2-2係使用與合成例A-2-1之聚合物(A-2-1)的製作方法相同之製備方法,不同之處在於合成例B-2-1至合成例B-2-2改變聚合物物中原料的種類與使用量。其配方分別如第2表所示,此處不另贅述。Synthesis Examples B-2-1 and B-2-2 utilize the same preparation method as the polymer (A-2-1) from Synthesis Example A-2-1. The difference lies in the changes in the types and amounts of raw materials used in the polymers. Their respective formulations are shown in Table 2 and are not further detailed here.
製備液晶配向劑、液晶配向膜及液晶顯示元件Preparation of liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
實施例1Example 1
秤取50重量份之合成例A-1-1所製得的聚合物(A-1-1)、50重量份之合成例B-1-1所製得的聚合物(B-1-1)與2000重量份之NMP(C-1),並於室溫下攪拌混合,即可製得實施例1之液晶配向劑。Weigh 50 parts by weight of the polymer (A-1-1) prepared in Synthesis Example A-1-1, 50 parts by weight of the polymer (B-1-1) prepared in Synthesis Example B-1-1, and 2000 parts by weight of NMP (C-1), and stir and mix them at room temperature to prepare the liquid crystal alignment agent of Example 1.
將前述所製得的液晶配向劑旋轉塗佈在玻璃基板上,且玻璃基板上形成有畫素電極,其中畫素電極為具有一對ITO電極(電極寬為10 μm,電極間隔為10 μm,而電極高度為50 nm)之IPS驅動用電極,該對ITO電極係分別具有櫛齒狀之形狀,且彼此之櫛齒狀部份係以分開並咬合之方式來配置。然後,將塗佈有液晶配向劑的玻璃基板在80℃的加熱板上乾燥3分鐘後,在250℃之熱風循環式烘箱中烘烤30分鐘,即可形成膜厚為100 nm的塗膜。The prepared liquid crystal alignment agent was spin-coated onto a glass substrate, where pixel electrodes were formed. These were IPS driver electrodes consisting of a pair of ITO electrodes (10 μm in width, 10 μm in spacing, and 50 nm in height). The ITO electrodes each had a serrated shape, with the serrated portions arranged in a spaced-apart, interlocking configuration. The glass substrate coated with the liquid crystal alignment agent was then dried on an 80°C hot plate for 3 minutes and then baked in a 250°C hot air circulation oven for 30 minutes to form a 100 nm thick film.
透過一偏光板,對塗膜面照射波長為254 nm的紫外線後,在250℃之熱風循環式烘箱中烘烤30分鐘,以製得具有液晶配向膜的基板。同樣地,在對向基板上形成塗膜並施予配向處理,所述對向基板為未有電極形成的但具有高度為4 μm之柱狀間隔件的玻璃基板。The coated surface was irradiated with 254 nm UV light through a polarizing plate and then baked in a 250°C hot air circulating oven for 30 minutes to produce a substrate with a liquid crystal alignment film. Similarly, a coating was formed and then aligned on a counter substrate, a glass substrate without electrodes but with 4 μm-high columnar spacers.
上述二個基板為一組,在其中一者上印刷密封劑,而另一者以與液晶配向膜面對且配向方向為0°的方式,黏合二者,之後硬化密封劑以製得空的晶胞。將這個空晶胞以減壓注入法,注入液晶MLC-2041(Merck公司製),並密封注入口,即可製得實施例1之液晶顯示元件。所得之液晶顯示元件以下列之評價方式進行評價,其結果如第3表所示,其中驅動後亮度變化率的檢測方法容後再述。The two substrates were assembled into a set. A sealant was printed on one of the substrates, and the other substrate was bonded together with the liquid crystal alignment film facing each other and aligned at 0°. The sealant was then cured to create an empty cell. This empty cell was then injected with liquid crystal MLC-2041 (Merck) using a reduced-pressure injection method, and the injection port was sealed to produce the liquid crystal display device of Example 1. The resulting liquid crystal display device was evaluated using the following evaluation method, and the results are shown in Table 3. The method for measuring the brightness change rate after driving is described later.
實施例2至實施例10與比較例1至比較例7Examples 2 to 10 and Comparative Examples 1 to 7
實施例2至實施例10與比較例1至比較例7係使用與實施例1之液晶配向劑、液晶配向膜及液晶顯示元件相同之製備方法,不同之處在於實施例2至實施例10與比較例1至比較例7係改變液晶配向劑中原料的種類及使用量,其配方及評價結果分別如第3表所示,此處不另贅述。Examples 2 to 10 and Comparative Examples 1 to 7 use the same preparation method for the liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element as that of Example 1. The difference is that Examples 2 to 10 and Comparative Examples 1 to 7 change the type and usage of the raw materials in the liquid crystal alignment agent. Their formulas and evaluation results are shown in Table 3, respectively, and are not further described here.
評價方式Evaluation method
驅動後亮度變化率Brightness change rate after driving
將偏光板彼此垂直地附接至前述實施例1至實施例32與比較例1至比較例5所製備的液晶顯示元件的頂面和底面。將附接有偏光板的液晶顯示單元放置在10000 cd/m 2的背光上,並使用亮度計PR-788觀察在黑暗狀態下的亮度(L0)。然後,將液晶在室溫與5 V的交流電壓下驅動1小時,並在斷開液晶顯示單元的電壓時,以前述之方法觀察黑暗狀態下的亮度(L1)。以下式計算亮度變化率,並依據以下基準評價液晶顯示單元之驅動後亮度變化率。 ※:驅動後亮度變化率<1%。 ◎:1%≦驅動後亮度變化率<2%。 ○:2%≦驅動後亮度變化率<3%。 △:3%≦驅動後亮度變化率<5%。 ╳:驅動後亮度變化率≧5%。 Polarizing plates were attached perpendicularly to each other on the top and bottom surfaces of the liquid crystal display elements prepared in Examples 1 to 32 and Comparative Examples 1 to 5. The liquid crystal display unit with the polarizing plates attached was placed on a 10,000 cd/ m2 backlight, and the brightness (L0) in the dark state was observed using a luminance meter PR-788. The liquid crystal was then driven at room temperature and an AC voltage of 5 V for 1 hour, and when the voltage of the liquid crystal display unit was disconnected, the brightness (L1) in the dark state was observed using the aforementioned method. The brightness change rate was calculated using the following formula, and the brightness change rate of the liquid crystal display unit after driving was evaluated based on the following criteria. ※: Brightness change rate after driving <1%. ◎: 1% ≤ Brightness change rate after driving <2%. ○: 2% ≤ Brightness change rate after driving <3%. △: 3% ≤ Brightness change rate after driving <5%. ╳: Brightness change rate after driving ≥5%.
由第3表之結果可知,若本發明液晶配向劑之聚合物(A)不包含如式(I)與式(II)所示之結構時,含有此液晶配向劑所形成之液晶配向膜的液晶顯示單元之驅動後亮度變化率不佳。其中,於式(I)中,當A 1與A 2代表自苯環、吡啶環或嘧啶環的環部分去除二個氫原子而成的二價基團,其中環部分可以具有取代基,且A 1和A 2是相同的,而Z 1代表 ,且n代表1至5之整數時,利用此液晶配向劑所製得之液晶配向膜可進一步降低液晶顯示元件的驅動後亮度變化率。於式(II)中,當Y 21與Y 22分別獨立地代表-O-或-S-時,利用此液晶配向劑所製得之液晶配向膜可更進一步降低液晶顯示元件的驅動後亮度變化率。 From the results in Table 3, it can be seen that if the polymer (A) of the liquid crystal alignment agent of the present invention does not contain the structure shown in formula (I) and formula (II), the liquid crystal alignment film formed by the liquid crystal display unit containing the liquid crystal alignment agent has a poor brightness change rate after driving. Wherein, in formula (I), when A1 and A2 represent a divalent group formed by removing two hydrogen atoms from the ring portion of a benzene ring, a pyridine ring or a pyrimidine ring, wherein the ring portion may have a substituent, and A1 and A2 are the same, and Z1 represents When n represents an integer from 1 to 5, a liquid crystal alignment film produced using this liquid crystal alignment agent can further reduce the brightness variation rate of a liquid crystal display device after actuation. In formula (II), when Y 21 and Y 22 independently represent -O- or -S-, a liquid crystal alignment film produced using this liquid crystal alignment agent can further reduce the brightness variation rate of a liquid crystal display device after actuation.
另外,當本發明液晶配向劑包含聚合物(B)時,若四羧酸二酐組份(b1)包含四羧酸二酐化合物(b1-1)時,利用此液晶配向劑所製得之液晶配向膜可進一步降低液晶顯示元件的驅動後亮度變化率;若二胺組份(b2)包含二胺化合物(b2-1)時,利用此液晶配向劑所製得之液晶配向膜可進一步降低液晶顯示元件的驅動後亮度變化率。In addition, when the liquid crystal alignment agent of the present invention contains a polymer (B), if the tetracarboxylic dianhydride component (b1) contains a tetracarboxylic dianhydride compound (b1-1), the liquid crystal alignment film prepared using this liquid crystal alignment agent can further reduce the brightness change rate of the liquid crystal display element after driving; if the diamine component (b2) contains a diamine compound (b2-1), the liquid crystal alignment film prepared using this liquid crystal alignment agent can further reduce the brightness change rate of the liquid crystal display element after driving.
需補充的是,本發明雖以特定的化合物、組成、反應條件、製程、分析方法或特定儀器作為例示,說明本發明之光配向法用的液晶配向劑、液晶配向膜與液晶顯示元件,惟本發明所屬技術領域中任何具有通常知識者可知,本發明並不限於此,在不脫離本發明之精神和範圍內,本發明之光配向法用的液晶配向劑、液晶配向膜與液晶顯示元件亦可使用其他的化合物、組成、反應條件、製程、分析方法或儀器進行。It should be noted that although the present invention uses specific compounds, compositions, reaction conditions, processes, analytical methods or specific instruments as examples to illustrate the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element used in the photo-alignment method of the present invention, anyone with ordinary knowledge in the technical field to which the present invention belongs will understand that the present invention is not limited thereto. Without departing from the spirit and scope of the present invention, the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element used in the photo-alignment method of the present invention may also be carried out using other compounds, compositions, reaction conditions, processes, analytical methods or instruments.
雖然本發明已以實施方式揭露如上,然其並非用以限定本發明,在本發明所屬技術領域中任何具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。Although the present invention has been disclosed above in the form of embodiments, it is not intended to limit the present invention. Anyone with ordinary knowledge in the technical field to which the present invention belongs may make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention shall be determined by the scope of the attached patent application.
(無)(without)
(無)(without)
國內寄存資訊(請依寄存機構、日期、號碼順序註記) 無 國外寄存資訊(請依寄存國家、機構、日期、號碼順序註記) 無 Domestic Storage Information (Please enter in order by institution, date, and number) None International Storage Information (Please enter in order by country, institution, date, and number) None
(無)(without)
Claims (9)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW112140282A TWI892269B (en) | 2023-10-20 | 2023-10-20 | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element |
| CN202411440858.XA CN119859534A (en) | 2023-10-20 | 2024-10-15 | Liquid crystal alignment agent for photoalignment method, liquid crystal alignment film and liquid crystal display assembly |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW112140282A TWI892269B (en) | 2023-10-20 | 2023-10-20 | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202517712A TW202517712A (en) | 2025-05-01 |
| TWI892269B true TWI892269B (en) | 2025-08-01 |
Family
ID=95388104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW112140282A TWI892269B (en) | 2023-10-20 | 2023-10-20 | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN119859534A (en) |
| TW (1) | TWI892269B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202321428A (en) * | 2021-08-06 | 2023-06-01 | 日商日產化學股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| TW202330691A (en) * | 2021-10-28 | 2023-08-01 | 日商日產化學股份有限公司 | Polymer composition, liquid crystal aligning agent, resin film, liquid crystal alignment film, method for producing liquid crystal display element, and liquid crystal display element |
| TW202340328A (en) * | 2022-04-07 | 2023-10-16 | 日商捷恩智股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, manufacturing method thereof and liquid crystal element wherein the liquid crystal alignment agent includes a polyamic acid or a derivative thereof obtained by reacting a tetracarboxylic acid derivative with a diamine |
-
2023
- 2023-10-20 TW TW112140282A patent/TWI892269B/en active
-
2024
- 2024-10-15 CN CN202411440858.XA patent/CN119859534A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202321428A (en) * | 2021-08-06 | 2023-06-01 | 日商日產化學股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| TW202330691A (en) * | 2021-10-28 | 2023-08-01 | 日商日產化學股份有限公司 | Polymer composition, liquid crystal aligning agent, resin film, liquid crystal alignment film, method for producing liquid crystal display element, and liquid crystal display element |
| TW202340328A (en) * | 2022-04-07 | 2023-10-16 | 日商捷恩智股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, manufacturing method thereof and liquid crystal element wherein the liquid crystal alignment agent includes a polyamic acid or a derivative thereof obtained by reacting a tetracarboxylic acid derivative with a diamine |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202517712A (en) | 2025-05-01 |
| CN119859534A (en) | 2025-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2024029576A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| JP7343059B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI892269B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI901102B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI897382B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI888820B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI900100B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI887964B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI863615B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI865340B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI889344B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal photo alignment film and liquid crystal display element | |
| TWI859005B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI903532B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI911714B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI905717B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| TWI902144B (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element | |
| JP7302744B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| CN120829783A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element for photo-alignment method | |
| CN120290193A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element for photo-alignment method | |
| CN120399717A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display component for photo-alignment method | |
| TW202532620A (en) | Liquid crystal alignment agent for photoalignment method, liquid crystal alignment film, and liquid crystal display element | |
| CN120829782A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element for photo-alignment method | |
| CN119490852A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element for photo-alignment method | |
| TW202538041A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TW202546199A (en) | Liquid crystal alignment agent for photo-alignment, liquid crystal alignment film and liquid crystal display element |